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Structured Abstract 
Objectives: To assess the effects of orthodontic treatment for Class III incisors in children 
and adolescents. 
Design: A Cochrane systematic review. 
Method:  The following databases were searched up to 7
th
 January 2013: Cochrane Oral 
Health Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL), 
MEDLINE via OVID, EMBASE via OVID. 
Selection criteria: All randomised controlled trials of orthodontic treatments to correct Class 
III incisors. Trials were eligible for inclusion in the review if they recruited children and/or 
adolescents (aged 16 or less) receiving orthodontic treatment to correct Class III incisors. 
Trials including patients with a cleft lip and/or palate or other cranio-facial 
deformity/syndrome were excluded as were trials that had recruited less than 80% children or 
adolescents or patients who had previously received surgical orthognathic treatment. Active 
interventions included: orthodontic braces, chin cups, facemasks, reverse headgear, bone-
anchored appliances or any other intra or extra-oral appliance aiming to correct Class III 
incisors. Controls included: No treatment, delayed treatment, other active intervention. 
Types of Outcome Measures - Primary: Prominence of the lower front teeth (measured in mm 
or by any index of malocclusion). Secondary: Relationship between upper and lower jaw; 
psychosocial measures; patient satisfaction; jaw joint problems. Adverse effects: Health of 
the gums; damage to the teeth e.g. tooth decay. Outcomes were recorded at all ages reported. 
The results were reported according to the most common endpoints. Adverse effects were 
recorded and the results reported in descriptive terms.  
Data collection and analysis: The titles and abstracts of the search results were examined to 
exclude obviously irrelevant reports. Full text reports of potentially eligible studies were 
examined for compliance with the eligibility criteria. Screening of references, data extraction 
and assessment of the risk of bias of included studies, was performed independently and in 
duplicate by two review authors. The mean differences, with 95% confidence intervals, were 
calculated for continuous data. Meta-analysis was only used when studies of similar 
comparisons were reporting comparable outcome measures. A fixed-effect model was used. 
I
2
 statistics were used as measures of statistical heterogeneity. 
Results: Seven randomised controlled trials were included in this review. Of these, four 
reported on the use of a facemask, two on the chin cup, one on the tandem traction bow 
appliance and one on mandibular headgear. One study reported on both the chin cup and 
mandibular headgear appliances. Three trials (n=155) reported ANB differences immediately 
after treatment with a facemask when compared to an untreated control. The pooled data, for 
ANB difference, showed a statistically significant mean difference of 3.93 degrees (95%CI 
3.46 to 4.39; P<0.0001) in favour of the facemask. There was significant heterogeneity 
between these studies (I
2
=82%). One well designed trial, with a low risk of bias, reported 
outcomes of the use of the facemask compared to an untreated control at 3 years’ follow-up. 
This showed that improvements in overjet and ANB were still present at 3 years. However, 
there was no evidence of improved self-concept. The remaining trials each evaluated a 
different comparison and reported different outcomes so no meta-analysis was possible. 
Conclusions: There is some evidence that the use of a facemask, to correct prominent lower 
front teeth in children, is effective when compared to no treatment on a short term basis. 
However, in view of the general poor quality of the included trials, these results should be 
interpreted with caution. Further randomised controlled trials, with long follow-up, are 
required. 
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Abstract 
Background   
Prominent lower front teeth (reverse bite; under bite; Class III incisors) may be due to a 
combination of the jaw and/or tooth positions. The upper jaw (maxilla) can be too far back 
and/or the lower jaw (mandible) too far forward. Class III incisors can also occur if the upper 
front teeth are tipped back and/or the lower front teeth are tipped forwards. Different 
treatment approaches have been described to correct Class III incisors in children and 
adolescents. 
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Objectives   
To assess the effects of orthodontic treatment for Class III incisors in children and 
adolescents. 
 
Search methods   
The following databases were searched: Cochrane Oral Health Group Trials Register (to 7
th
 
January 2013), Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane 
Library, 2012, Issue 12), MEDLINE via OVID (1946 to 7
th
 January 2013), EMBASE via 
OVID (1980 to 7
th
 January 2013). Handsearching done as part of the Cochrane Worldwide 
Handsearching Programme and uploaded to CENTRAL was included. 
 
Selection criteria   
Types of Studies - Randomised controlled trials of orthodontic treatments to correct Class III 
incisors. 
Types of Participants - Trials were eligible for inclusion in the review if they recruited 
children and/or adolescents (aged 16 or less) receiving orthodontic treatment to correct Class 
III incisors. 
Trials including patients with a cleft lip and/or palate or other cranio-facial 
deformity/syndrome were excluded as were trials that had recruited less than 80% children or 
adolescents or patients who had previously received surgical treatment for their Class III 
malocclusion. 
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Types of Interventions - Active interventions included: orthodontic braces (removable, fixed, 
and functional), chin cups, facemasks, reverse headgear, bone-anchored appliances or any 
other intra or extra-oral appliance aiming to correct Class III incisors. 
Controls included: No treatment, delayed treatment, other active intervention. 
Types of Outcome Measures - Primary: Prominence of the lower front teeth (measured as the 
overjet in mm or by any index of malocclusion). 
Secondary: Relationship between the upper and lower jaw; psychosocial measures; patient 
satisfaction; jaw joint problems. 
Adverse effects: Health of the gums; damage to the teeth e.g. tooth decay. 
Outcomes were recorded at all ages reported. The results were reported according to the most 
common endpoints. Adverse effects were recorded and the results reported in descriptive 
terms. 
 
Data collection and analysis   
The titles and abstracts of the search results were screened to exclude obviously irrelevant 
reports, being generally over inclusive at this stage. Full text reports of potentially eligible 
studies were examined for compliance with the eligibility criteria. Screening of titles and 
abstracts, data extraction and assessment of the risk of bias of included studies, was 
performed independently and in duplicate by two review authors. The mean differences, with 
95% confidence intervals, were calculated for continuous data. Meta-analysis was only used 
when studies of similar comparisons were reporting comparable outcome measures. A fixed-
effect model was used. I
2
 statistics were used as measures of statistical heterogeneity. 
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Results   
Seven randomised controlled trials were included in this review. Of these, four reported on 
the use of a facemask, two on the chin cup, one on the tandem traction bow appliance and one 
on mandibular headgear. One trial reported on both the chin cup and mandibular headgear 
appliances. 
Three trials (n=155) reported ANB (an angular measurement relating the positions of the top 
and bottom jaws) differences immediately after treatment with a facemask when compared to 
an untreated control. The pooled data showed a statistically significant mean difference in 
ANB of 3.93 degrees (95%CI 3.46 to 4.39; P<0.0001) in favour of the facemask. There was 
significant heterogeneity between these studies (I
2
=82%). This is likely to have been caused 
by the different populations studied and of different ages at time of treatment. 
One well designed trial, with a low risk of bias, reported outcomes of the use of the facemask 
compared to an untreated control at 3 years’ follow-up. This showed that improvements in 
overjet and ANB were still present at 3 years’, however there was no evidence of improved 
self-concept. 
The remaining trials each evaluated a different comparison and reported different outcomes 
so no meta-analysis was possible. 
 
Authors' conclusions   
There is some evidence that the use of a facemask, to correct Class III incisors in children, is 
effective when compared to no treatment on a short term basis. However, in view of the 
general poor quality of the included trials, these results should be interpreted with caution. 
Further randomised controlled trials, with long follow-up, are required. 
11 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
People with prominent lower teeth may also be described as having a reverse bite, underbite 
or, within the dental profession, as possessing a Class III incisor relationship. This is often 
associated with a Class III skeletal discrepancy. This malocclusion may be considered 
disadvantageous due to appearance, problems with eating, problems with speech and a 
possibility it may lead to jaw joint problems.
1-3
 Whilst relatively uncommon in Caucasians, it 
is far more common in Oriental populations.
4-8
 
Orthodontics is the branch of dentistry concerned with the growth of the jaws and face, 
development of the teeth and the way the teeth and jaws bite together.
9
 Orthodontic treatment 
12 
 
involves the use of a variety of appliances, some fixed and some removable, to correct 
discrepancies in the alignment of the teeth and in the way in which the teeth meet together. 
Orthodontic treatment for a Class III malocclusion, if required, happens either early, during 
childhood, with the use of orthodontic appliances alone, or once growth has ceased when it 
may be combined with a surgical procedure, to correct not only the occlusion but also the 
underlying skeletal discrepancy. Many different appliances have been tried, at many different 
stages of development, to correct a Class III malocclusion. 
The aim of this research is to report the outcome of interventions to correct Class III incisors 
in children and adolescents. The review will assess the relative effectiveness of these 
interventions when compared with each other and when compared with no treatment. It will 
aim to summarise the available literature and also to appraise critically the methodology used 
in the included journal articles. In addition to this, if previous research is found to be deficient 
in any areas then this review will aim to suggest possible areas for future research. 
Suggestions will be made for how future research should be carried out in order to maximise 
its value. 
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Chapter 2: Literature Review 
2.1 Systematic Reviews 
Over two million journal articles are published every year in the biomedical literature.
10
 It is 
impossible for the majority of healthcare professionals to read every article published in their 
area of interest, speciality or expertise due to the sheer bulk of research and the amount of 
time available to read it. Health care providers, researchers, and policy makers are inundated 
with unmanageable amounts of information and they need a way to integrate existing 
information efficiently and provide data for rational decision making.
10
 Therefore, this has 
led to a relatively new form of publication type which identifies all the research about a 
particular subject or question, analyses it and then reports the overall findings with 
suggestions for future research: the systematic review.
11
 Chalmers has defined the systematic 
review as a review, which has been prepared using a systematic approach to minimising 
biases and random errors, with the different components of the process being documented in 
the methods section.
10
 It has been stated that without the systematic review there would be a 
serious risk that “tens of billions of dollars, already spent on hundreds of thousands of 
14 
 
controlled trials, would be wasted due to the inaccessibility of the data.”12 A systematic 
review attempts to collate all empirical evidence, meeting pre-specified eligibility criteria, in 
order to answer a specific research question. It uses explicit, systematic methods, selected 
with a view to minimising bias, therefore providing more reliable results from which valid 
conclusions can be drawn and decisions made.
13
 In addition, a greater level of generalisability 
of scientific findings can be established in systematic reviews. The diversity of multiple 
reviewed studies provides an interpretive context not available in any one study. This is 
because studies addressing similar questions often use different eligibility criteria for 
participants, different definitions of disease, different methods of measuring or defining 
exposure, different variations of a treatment, and different study designs.
10
 A further 
advantage of the systematic review is the ability to combine the data from multiple studies 
into a single meta-analysis. This leads to an increased level of statistical power and therefore 
increases the chances of finding a true result. 
The systematic nature of the methodology ensures that the risk of not including all available 
research, in that particular area of research, is minimised. By placing all of this research into 
a single journal article, it offers an easily accessible and reliable source for guiding clinicians 
as well as policy makers and potential researchers. 
There has been an exponential increase in the popularity of systematic reviews over the past 
30 years. Prior to 1982 there was roughly one systematic review published a year. By 1992, 
the number had risen to 500 a year and by 2007 this number was up to 2,500.
11, 14
 Clinicians 
like systematic reviews because they efficiently integrate existing information and provide 
data for rational decision making.
10
 They give a clinician a realistic chance of being able to 
keep up to date with current research and its results, in many different research areas. 
Systematic reviews are increasingly gaining acceptance as a starting point in the development 
of evidence-based clinical practice guidelines and to help design primary research and ensure 
15 
 
it is ethically justified.
14
 Prior to starting a piece of research, systematic reviews should be 
sought to ensure that the research to be carried out is not answering a question already 
answered and is targeted to avoid wasting valuable resources. One of the main reasons for the 
substantial increase in systematic reviews has been the success of the Cochrane 
Collaboration.
15
 
2.2 The Cochrane Collaboration 
The Cochrane Centre, established in 1993, evolved in response to Archie Cochrane’s 
criticism of health professions for not having organised, systematic, periodically updated 
reviews of all relevant randomised controlled trials.
11, 13
 The Cochrane Collaboration’s 
primary aim is to help people, including clinicians, patients, funding organisations and 
researchers alike, make informed decisions about healthcare by preparing, maintaining and 
promoting the accessibility of systematic reviews and the evidence that underpins them.
13
 
The work of the Cochrane Collaboration is underpinned by ten key principles (Box 1).  
A Cochrane systematic review must adhere to strict guidelines and methodology. Green 
states that “the advances in methodology have led to improvements in the internal validity of 
systematic reviews and trials”, for example highlighting the importance of allocation 
concealment and blinding,  also influencing broader issues of research conduct.
12
 More 
recently, a greater emphasis has been placed on the importance of sample size calculations to 
ensure that a study has sufficient power to detect a difference if one exists. This may help 
prevent the failure of studies to find a true positive and therefore waste time, effort and 
resources.
13 
A Cochrane systematic review is very strict about the types of research that are included. In 
order to give the most reliable and valid conclusion only the greatest level of research is 
16 
 
encouraged for inclusion: the randomised controlled trial. If there are no randomised 
controlled trials available then the use of other study designs is permitted.
13 
The risk of bias tool has been developed in order to allow every article, that is included in a 
review, to be assessed for potential bias that may have influenced the results of the trial. This 
is useful in two ways. Firstly, it allows a reviewer to assess the methodology being used in a 
piece of research accurately. Secondly, it can be used by potential researchers to ensure that 
their research methodology is designed in a way in which bias will be minimised.
13 
The work of the Cochrane Collaboration revolves around 51 review groups covering the 
majority of areas of medicine and surgery.
13
 One of these groups is the Oral Health Group 
(OHG), which is responsible for the reviews in the field of dentistry. Up to 2013 the OHG 
has been responsible for 18 published reviews in the speciality of orthodontics and there are a 
further 11 at the protocol stage. It is within this group that the proposed systematic review, 
into the early treatment of Class III incisors, was carried out. 
 
 
 
 
 
 
 
Box 1: The principles of the Cochrane Collaboration.
13
 
 
1. Collaboration, by internally and externally fostering good communications, open decision-
making and tea work. 
2. Building on the enthusiasm of individuals, by involving and supporting people of different 
skills and backgrounds. 
3. Avoiding duplication by good management and co-ordination, maximising economy and 
effort.
4. Minimising bias, thorough scientific rigour, broad participation, avoiding conflicts of interest. 
5. Keeping up to date, by a commitment to ensure that Cochrane reviews are maintained 
through identification and incorporation of new evidence. 
6. Striving for relevance, promoting the assessment of healthcare interventions using outcomes 
that matter to people making choices in health care. 
7. Promoting access, by wide dissemination of the outputs of the Collaboration, taking 
advantage of strategic alliances, and by promoting appropriate prices, content and media to 
meet the needs of users worldwide. 
8. Ensuring quality, by being open and responsive to criticism, applying advances in 
methodology, and developing systems for quality improvement. 
9. Continuity, by ensuring that responsibility for reviews, editorial processes and key functions 
is maintained and renewed. 
10. Enabling wide participation in the work of the Collaboration by reducing barriers to 
contributing and by encouraging diversity. 
17 
 
 
2.3 Definition and Prevalence of Class III Incisors 
In layman’s terms, Class III incisors occur when the bottom teeth meet in front of the top 
teeth and the individual may be said to have prominent lower front teeth. The British 
Standards Institute describes the Class III incisal relationship as existing when the lower 
incisor tips occlude or lie anterior to the cingulum plateau of the upper incisors.
16
 Class III 
incisors often occur as part of a Class III malocclusion. Angle described the Class III 
malocclusion as occurring when the mesiobuccal cusp of the permanent maxillary first molar 
occludes distal to the buccal groove of the permanent mandibular first molar.
17
 In the 
Caucasian population, the prevalence of a Class III malocclusion ranges from 0.48 to 4%.
6, 7
 
In the Japanese population, it is in the region of 10%.
8
 However, in the Chinese population it 
has been found to be considerably higher, between 14 to 21%.
4, 5
 This relative prevalence has 
influenced the research with much of the work into a Class III malocclusion and its treatment, 
being undertaken in China and Japan.  
2.4 Aetiology of a Class III Malocclusion 
Until the 1970s, the terms Class III malocclusion and mandibular prognathism were virtually 
synonymous.
18
 Since then, cephalometric work has shown that the cause of a Class III 
malocclusion is in fact multifactorial.
18-21
 Every component of the craniofacial skeleton has, 
at one time, been implicated as the causative factor.
19
 Sanborn separated the causes into 4 
groups: 
 Group A: Mandibular prognathism with a normal maxillary position (45%) 
 Group B: Maxillary retrognathia with normal mandibular position (33%) 
 Group C: Normal maxillary and mandibular positions (9.5%) 
18 
 
 Group D: Maxillary retrognathia and mandibular prognathia (9.5%).21 
Jacobson et al. found similar results,
18
 whilst Ellis and McNamara
19
 found a greater 
percentage of Class III malocclusions could be attributed to maxillary retrusion. In 
addition to noting the role of solely the dentition and not their skeletal bases, they also 
added that excessive lower facial height was a frequent contributor. They suggested a 
possible 10 combinations of skeletodental components of a Class III malocclusion (Table 
1).  
 
Table 1: Combinations of skeletodental combinations occurring in a Class III malocclusion 
and their relative frequency.
19
 
In addition to the roles of the relative maxillary and mandibular protrusion, a role has also 
been implicated for the natural head position and posture as well as the cranial base angle. 
Cole suggested that cranial base orientation should be added to the list of theoretical causes 
of prognathism.
22
 In the case of a Class III skeletal relationship, the cranial base angle may be 
reduced leading to relative protrusion of the mandible in relation to the maxilla. This in turn 
will result in a Class III incisal relationship. 
In some cases, a Class III incisal relationship may be attributed to a functional forward 
displacement of the mandible as a result of retroclined maxillary incisors, often referred to as 
19 
 
a pseudo-Class III relationship.
23
 This can be of significance when assessing a patient, 
because when the patient bites into maximum intercuspation the relationship between the 
mandible and maxilla may appear worse than is actually the case. 
Due to the difficulty in treating patients with a Class III malocclusion, emphasis has been 
placed on early diagnosis and prediction. Jacobson et al. found that while 60% of children 
with a Class III malocclusion had mandibular and maxillary measurements within normal 
limits, only 14% of adults did.
18
 This is strongly suggestive that with growth, there is a 
worsening of maxillomandibular disharmony. Guyer et al. found that, even in children, a 
Class III malocclusion does not indicate a typical facial skeletal pattern but a combination of 
aberrations in the craniofacial complex.
20
 Williams et al. agreed, stating no one single factor 
could distinguish a Class III group from a Class I group and therefore act as a key to 
prediction.
24
 Later, Chang et al. looked at 80 children who went on to have either Class I or 
III malocclusions. The most significant differences, in the primary dentition, were found in 
the anteroposterior intermaxillary skeletal relationships with a reduction in ANB, angle of 
convexity, Wits appraisal and AF-BF distance.
25
 Therefore, although no single indicator can 
be determined, a tendency for a morphological difference between the maxilla and mandible 
in a Class III individual and a Class I individual exists and this difference occurs early.
20
 
More recently this has been supported on a Korean population where Choi et al. found that 
some of the cephalometric values are highly reliable for use to diagnose skeletal Class III 
malocclusion in the deciduous dentition.
26
 
More recent work has focused on the role of genetics in the development of a Class III 
malocclusion. It has been suggested that the cartilage of the mandibular condyle is responsive 
to biophysical environmental change and it is likely that a Class III malocclusion might be 
precipitated under these biomechanical conditions by the inheritance of genes predisposing to 
a Class III phenotype.
27
 Cruz et al. looked at 2562 individuals from 55 families. The majority 
20 
 
of pedigrees suggested an autosomal dominant inheritance. Heritability of mandibular 
prognathism was estimated to be 0.316 therefore suggesting a major gene influencing the 
expression of mandibular prognathism with clear signs of Mendelian inheritance.
28
 A study 
of 13 European noble families has also shown that mandibular prognathism may be 
determined by a single autosomal dominant gene.
29
 It appears likely, however, that this major 
gene is influenced by other genes as well as environmental factors.
27, 28
 When looking at 
specific genes, a number of reports document the influence of genes involved in the 
regulation of mandibular morphogenesis. Genes including IHH, PTHLH, IGF-1, and VEGF, 
and variations in their levels of expression play an important role in the aetiology of Class III 
malocclusion.
27
 A link between genetic polymorphisms in EPB41 gene and mandibular 
prognathism has been shown.
30
 Certain growth hormone receptor gene polymorphisms are 
related to mandibular height and RUNX2 is one of many biological factors influencing the 
development and growth of condylar cartilage in humans.
31, 32
 
Currently, genetics is yet to allow prediction of growth. It must also be noted that much of the 
research into Class III genetics focuses solely on mandibular prognathism and as discussed 
earlier, much of the cause of a Class III malocclusion is attributable to maxillary retrusion. 
However, it is likely that in the future use of these genes will allow early diagnosis, early 
treatment planning, prediction of growth and possibly alternative treatment modalities. 
  
2.5 Treatment of Class III Malocclusions 
In orthodontics, Class III malocclusions are considered amongst the most difficult to treat.
33
 
The main focus of concern for a Class III patient, presenting with a concave facial profile, 
retrusive nasomaxillary area and protrusive lower face is often their profile, not their 
occlusion.
1, 34
 Studying the reasons for seeking treatment to correct a Class III malocclusion, 
21 
 
Zhou et al. found that by far the greatest reason was that of appearance, followed by problems 
with chewing, speaking and rarely breathing.
3
 Problems with the temporomandibular joint 
have also been reported, although evidence for a link is weak.
2, 35
 Treatment of a Class III 
malocclusion is either orthopaedic treatment of a growing patient, delayed intervention in the 
form of corrective surgery at the end of active growth or, if maxillomandibular disharmony is 
mild, camouflage, is also possible.
36, 37
 Camouflage is particularly successful in the pseudo-
Class III malocclusion cases.
23
 If camouflage is not possible, early orthopaedic treatment is 
often indicated, because if left untreated they will ultimately comprise a significant 
percentage of the patients seeking orthognathic treatment as adults.
1
  
Orthognathic surgery is a relatively safe procedure however it is not without risk.
38, 39
 Peri-
operatively risks include major blood loss requiring transfusion, necessity for a tracheostomy, 
deep vein thrombosis and even death.
38, 39
 The most common post-operative complication is 
damage to the inferior alveolar nerve of which the reported incidence ranges from 0-85%.
40
 
Long-term damage to the infraorbital and facial nerves, whilst rare, is also of concern.
41, 42
 If 
surgery could be avoided, through early correction, these potential complications could be 
avoided.  
As surgical options are carried out once growth has ended, they are not applicable to this 
study. In the quest to find appropriate treatment regimens to correct a Class III malocclusion 
early, many options have been tried including: 
 Functional appliance treatment 
 Chin cup therapy 
 Mandibular cervical headgear 
 Facemask 
 Other methods of maxillary protraction 
 Camouflage 
22 
 
2.5.1 Functional Appliance Therapy 
Functional Jaw Orthopaedics has been in use since the late nineteenth century. In 1902, 
Robin introduced the monobloc for bimaxillary expansion. Andreasen furthered this work 
creating an appliance that fit loosely in the mouth and transmitted the forces generated from 
the muscles of mastication to the teeth and jaws bringing about the correction of 
malocclusions.
43
  
 
2.5.1.1 The Functional Regulator Appliance 
Frankel suggested that, by inserting his appliance, the development of the dentoalveolar 
structures could be influenced up to the apical base. Expanding the soft tissue encapsulating 
the dentition, so restricting the forces of the perioral bands, would allow the dentoalveolar 
processes to be further developed. This would, in turn, allow a Class I jaw and tooth 
relationship to develop.
44
 One of Frankel’s appliances was designed for a Class III 
malocclusion, the functional regulator 3 (FR-3).  
 
Figure 1: The Functional Regulator 3 (FR-3).
45
 
The buccal shields of the FR-3 appliance provoke tension of the soft tissues in the vestibular 
fold achieving expansion and remodelling of the dentoalveolar arch and apical base as well as 
23 
 
relieving unwanted pressure and applying traction. Therefore, in the upper arch the 
permanent teeth erupt more buccally with expansion of the dentoalveolar arch, so correcting a 
Class III tendency.
46
 
The results of investigations into the effects of the FR-3 are variable. The appliance has been 
shown to induce increased overjet, reduce SNB angle, increase ANB angle and improve soft 
tissue outcome.
47, 48
 It has been postulated that much of this improvement is due to 
principally dentoalveolar changes,
49
 however, Miethke et al. found that the appliance did 
stimulate development of the maxilla.
45
 This was supported cephalometrically by Kilic et al. 
who found the maxilla and surrounding soft tissues showed significant anterior movement 
whilst mandibular growth was restricted.
50
 It must be noted that all of this research was 
retrospective and used either no control group or an inappropriate control. 
 
2.5.1.2 The Removable Mandibular Retractor 
Tollaro et al. have suggested the use of the Removable Mandibular Retractor (RMR).
51
 This 
consists of a resin plate attached to the maxillary teeth with Adams clasps and a labial bow 
extending to the cervical margin of the mandibular incisors. The labial arch is activated so to 
be placed 2mm anterior to these teeth when the mandible is forced into maximum retrusion, 
therefore acting as a stop for sagittal movement of the mandible. Expansion screws and 
springs are used for the proclination of the upper incisors, if indicated.
52
 
Used in the deciduous dentition this appliance has been shown to produce a significant 
anterior morphogenic rotation of the mandible due to a more upward and forward direction of 
condylar growth and a reduced mandibular length.
52
 Whilst the research into the RMR has 
used an appropriate Class III control group it must again be criticised for being retrospective 
in nature. 
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Figure 2: The Removable Mandibular Retractor (RMR).
51
 
 
Other functional appliances found in the literature include the Bionator III and Class III 
Twin-block.
53, 54
 
 
2.5.2 Chin cup Therapy 
Chin cup therapy, sometimes referred to as chin cap therapy, has been used since the 
nineteenth century for the treatment of mandibular prognathism.
55
 The chin cup apparatus 
involves the use of an acrylic or metal prosthesis which sits on the patients chin with force 
applied to the occipital region of the skull (Figure 3). 
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Figure 3: An example of a patient wearing the chin cup appliance.
56
 
Forces used have ranged from 200-900g per side with most using between 200-250g.
33, 57, 58
 
The results from the literature vary widely. Whilst some research showed no effects,
55
 the 
majority found good initial results from the chin cup when used as an early intervention.
33, 56, 
59-62
  
The suggested mechanisms for success of this appliance have been: 
 Backward rotation or distal displacement of the mandible.  
 Retardation of mandibular growth.  
 Redirection of mandibular growth vertically. 
 Remodelling of the mandible through closure of the gonial angle. 
 Retardation of downward growth and reinforcement of forward maxillary growth. 
 Alteration in the condylar growth pattern. 56, 59, 60, 62, 63 
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There is further controversy with respect to the long term success. Deguchi et al. found long 
term success was possible with the chin cup.
56
 However, Sugawara et al. showed that whilst 
soft tissue profile was greatly improved during the initial stages of therapy, such changes 
were often not maintained.
61
 This is more recently supported by the work of Barrett et al. who 
showed that 2.6 years post-treatment, there were no significant skeletal changes in the 
mandible in either the vertical or horizontal direction and fewer than 50% had a favourable 
clinical outcome.
58
 
2.5.3 Mandibular Cervical Headgear 
Mandibular Cervical Headgear (MCH) uses bands on the lower first permanent molars and a 
connecting neck strap thus placing force through the centre of resistance of these teeth.
64
 
Used in cases of mandibular prognathism, the use of this headgear approach has been shown 
to lead to significant improvements in Wits appraisal, overjet and molar relationship.
64,
 
65
 The 
mechanism of improvement with this appliance is predominantly mandibular retrusion 
combined with dentoalveolar changes.
64
 
 
2.5.4 Facemask 
In 1944, Oppenheim published an article suggesting the possibility of treatment to result in 
maxillary protraction. However, it was not until 1971 that the modern facemask was 
reintroduced by Delaire.
66
 This design consisted of a forehead support,  a chincup, a prelabial 
arch, and a metal frame (Figure 4).
67
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Figure 4: A Delaire Facemask.
68
 
 
Multiple authors have modified the facemask in order to alter the angle or amount of force 
slightly but all rely on a similar mechanism of using the chin and forehead as a stable base 
against which to protract the maxilla using elastics.
67, 69-71
 
Several authors have found the success for early correction of a Class III malocclusion with a 
facemask lies in the region of 70-75%.
72, 73
 The facemask has been shown to produce 
maxillary and mandibular changes reliably, including:  
 anterior displacement of the maxilla 
 posterior rotation of the mandible 
 backward movement of the mandible 
 proclination of the maxillary incisors 
 retroclination of the mandibular incisors 
 increase in the mandibular plane angle 
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 increase in the anterior face height 
 increase in the skeletal profile convexity 
 improvement of the sagittal lip relationship  
 decrease in the soft tissue facial angle and convexity.34, 72, 74-79  
Therefore, recent work focuses on finding the conditions for producing the best long-term 
results. The cases that are suitable for facemask treatment tend to be those with a hypoplastic 
maxilla. In many of these cases, the use of some form of maxillary expander is often 
required. Midfacial orthopaedic expansion has been recommended for use in conjunction 
with protraction forces on the maxilla as it is thought to disrupt the circum-maxillary sutural 
system, initiate cellular responses within the sutures and, therefore, facilitate the orthopaedic 
effects of the facemask.
75, 80
 However, research has shown that facemask treatment is equally 
effective without rapid maxillary expansion and therefore cannot be recommended unless 
clinically indicated.
80, 81
 This would suggest that unless the patient requires expansion for 
other orthodontic reasons, no phase of pre-facemask expansion should be carried out.  
Conflicting results can be found in the literature regarding the ideal age for intervention with 
a facemask. Much of the research advocates intervention in the early mixed dentition.
74, 75, 82, 
83
 Saadia and Torres recommend intervention as young as a diagnosis is made, as young as 
3.
84
 However, Sung and Baik and Yuksel et al. noted no significant difference between the 
young and adolescent groups in their studies.
85, 86
 
 
2.5.5 Other Methods of Maxillary Protraction  
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2.5.5.1 Tandem Traction Bow Appliance 
The tandem traction bow appliance (TTBA) comprises of upper and lower splints covering 
the teeth, activator tubes embedded in the splints, a conventional headgear facebow used as a 
traction bow and elastics connecting the upper splint to the traction bow (Figure 5).
87
 The 
original appliance used 400-500g force per side at 20°, however, this has been modified to 
35°.
87
 
 
Figure 5: The modified tandem traction bow appliance (TTBA).
87
 
 
This appliance has also been shown to produce maxillary protrusion and mandibular 
retrusion.
87
 
 
2.5.5.2 Mini Maxillary Protractor 
The mini maxillary protractor has a maxillary expander, hooks embedded buccally within the 
acrylic in the molar and premolar regions, a mandibular plate, a chincup and a lower facebow 
attached to the chincup applying maxillary protraction with elastics (Figures 6, 7).
88
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Figure 6: The mini maxillary protractor. Extra-oral views.
88
 
Figure 7: The mini maxillary protractor. Intra-oral views.
88
 
This appliance has been shown to elicit forward maxillary movement, backward mandibular 
movement, protrusion of the upper incisors, retrusion of the lower incisors and opening of the 
mandibular plane angle.
88
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2.5.5.2 Modified Protraction Bow Appliance 
The modified protraction bow appliance (MPBA) uses bands on the molars connected with a 
palatal button, a chin pad on an acrylic facebow and elastics to connect and apply the 
required force.
89
 When used in the deciduous dentition this appliance has been shown to 
produce effective maxillary displacement.
90
 
 
2.5.5.3 Occipitomental Anchorage 
Lin et al. have carried out research into occipitomental anchorage for maxillary protraction 
(OMA), using buccal hooks on the upper first permanent molars and elastics to horns on a 
chin cap.
91
 
 
Figure 8: The Occipitomental anchorage (OMA) appliance.
91
 
OMA has been shown to cause backward mandibular rotation, forward maxillary movement 
and considerable dentoalveolar movement leading to effective anterior crossbite correction.
91
 
 
2.5.5.4 Bone-Anchored Maxillary Protraction 
De Clerck et al. have introduced an innovative bone-anchored maxillary protraction (BAMP) 
protocol, removing any extra-oral component. Using 4 surgically placed miniplates, 2 in the 
infrazygomatic crest of the maxillary buttress and 2 between the mandibular lateral incisors 
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and canines, elastics are used to connect them. A removable biteplane can be used to remove 
occlusal interferences.
92
 
 
 
Figure 9: Bone-Anchored Maxillary Protraction (BAMP).
92
 
 
Early indications are that this may be effective at producing maxillary advancement and 
posteriorly relocating the mandibular condyle leading to a marked improvement in 
intermaxillary relationship. Due to the force being directed at the bone, rather than the teeth, 
there is a reduction in the changes in incisal inclination.
92
  
Similar work has been carried out by Sar et al.
93
 Their protocol involves 2 miniplates placed 
lateral to the aperture piriformis regions of the maxilla. After a week the protraction starts 
using elastics from the hooks connected to a facemask. A splint removes occlusal 
interferences (Figure 10). Again, results are short-term but appear promising, achieving 
maxillary protraction quickly and with reduced dentoalveolar side-effects.
93
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Figure 10: Maxillary protraction with skeletal anchorage.
93
 
2.5.6 Camouflage 
In some cases with Class III incisal relationships, the maxillomandibular disharmony is mild 
and the ANB angle close to normal. These cases may be treated by camouflage, for example 
by proclining the upper labial segment and retroclining the lower labial segment.
94
 It has been 
shown that a wide range of skeletal discrepancy may be successfully camouflaged with solely 
tooth movement, however, it is only possible with mild to moderate skeletal malocclusions 
and realistic treatment objectives on behalf of the clinician are imperative.
36, 95, 96
  Kerr et al. 
found threshold values for the ANB and lower incisor angles at which point surgery was 
carried out over camouflage. These angles were ANB of -4° and lower incisor angle of 83°.
36
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Similar work by Stellzig-Eisenhauer et al. found that Wits appraisal, length of the anterior 
cranial base, ratio of the anteroposterior length of the maxilla to the anteroposterior length of 
the mandible and gonial angle could be used as predictors for which cases were treated by 
camouflage compared with surgery.
97
  A considerable problem is the inability to predict 
future growth and Bishara suggests treatment planning should be based on ‘worst case 
scenario’ assuming facial growth will continue unfavourably.98 Camouflage can be achieved 
using either fixed or removable appliances.  
2.5.6.1 Fixed Appliances 
Camouflage is most commonly carried out using fixed appliances.
96
 They are often used on 
the non-growing patient when other, orthopaedic or functional, treatments are no longer 
possible.
95, 96
 A fixed appliance that has been shown to be particularly successful in the early 
mixed dentition is the 2 x 4 appliance that successfully proclines the maxillary incisors using 
an advancing loop connected to the first permanent maxillary molars.
23
 
2.5.6.2 Removable Appliances 
The use of removable maxillary appliances to procline the maxillary incisors has also been 
shown to be successful.
99
  It has been shown that, as would be expected, there are no skeletal 
effects and all improvement in anterior relationship is solely due to maxillary incisor 
proclination.
100
 The proclination may be achieved with the use of a spring or screw in the 
appliance and aims to produce a positive, stable overjet at the end of treatment. Used in mild 
cases this has been shown be stable long term.
101
 
 
2.6 Conclusion 
Many appliances have been advocated for use in the correction of a Class III malocclusion in 
childhood. They have been used at different stages of development and for different 
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aetiological reasons. The methodology of some of the studies appears to be weak, especially 
with respect to the use of appropriate controls. 
It is the purpose of this Cochrane systematic review to identify all the literature in this area, 
collate the evidence from controlled and randomised clinical trials, determine the relative 
effectiveness of these interventions and suggest future areas for research. 
 
 
 
 
 
 
 
Chapter 3: Systematic Review 
3.1 Objectives 
The purpose of this systematic review was to test the null hypotheses that there were no 
differences in outcomes between: 
 different orthodontic interventions for correcting a reverse bite, 
 the age at which orthodontic treatment for a reverse bite is carried out, 
against the alternative hypotheses that there were differences. 
 
3.2 Methods 
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3.2.1 Criteria for Considering Studies for the Review 
 
3.2.1.1 Types of Studies 
All randomised controlled clinical trials of orthodontic treatments to correct prominent lower 
front teeth. 
 
3.2.1.2 Types of Participants 
Trials were eligible for inclusion in the review if they had recruited children and/or 
adolescents (aged 16 or less) receiving orthodontic treatment to correct prominent lower front 
teeth. 
Trials including patients with a cleft lip and/or palate or other cranio-facial 
deformity/syndrome were excluded as were trials that had recruited less than 80% children or 
adolescents or patients who had previously received surgical treatment for their prominent 
lower front teeth. 
 
3.2.1.3 Types of Interventions 
Active interventions included:  
 Orthodontic braces (removable, fixed, functional) 
 Chin cups 
 Face masks 
 Reverse headgear 
 Bone-anchored appliances. 
Controls included: 
 No treatment 
 Delayed treatment 
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 Other active intervention. 
 
3.2.1.4 Types of Outcome Measures 
 Primary: Prominence of the lower front teeth (measured in mm or by any index of 
malocclusion). 
 Secondary: Relationship between upper and lower jaw (measured in degrees or mm); 
psychosocial measures (using any measure of self-esteem, self-concept or self-
perception); patient satisfaction (using any form of questionnaire); jaw joint problems 
(using any index of temporomandibular jaw assessment tool). 
 Adverse effects: Health of the gums; damage to the teeth e.g. tooth decay. 
 
Outcomes have been recorded at all ages reported. The results have been reported according 
to the most common endpoints. Adverse effects have been recorded and the results reported 
in descriptive terms. 
 
3.2.2 Search Methods for Identification of Studies 
For the identification of studies included or considered for this review, detailed search 
strategies were developed for each database searched. These were based on the search 
strategy developed for MEDLINE (OVID) but revised appropriately for each database. The 
search strategy used a combination of controlled vocabulary and free text terms and was 
linked with the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying 
randomised trials (RCTs) in MEDLINE: sensitivity maximising version (2008 revision) as 
referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the Cochrane Handbook for 
Systematic Reviews of Interventions Version 5.1.0 (updated March 2011).
13
 Details of the 
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MEDLINE search are provided in Appendix 3. The search of EMBASE was linked to the 
Cochrane Oral Health Group filters for identifying RCTs (see Appendix 4). 
 
3.2.2.1 Databases Searched 
The following databases were searched: 
 The Cochrane Oral Health Group Trials Register (to 7 January 2013) (See 
Appendix 1) 
 The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane 
Library, 2012, Issue 12) (See Appendix 2) 
 MEDLINE via OVID (1946 to 7 January 2013) (See Appendix 3) 
 EMBASE via OVID(1980 to 7 January 2013) (See Appendix 4) 
 
3.2.2.2 Handsearching 
Only handsearching done as part of the Cochrane Worldwide Handsearching Programme and 
uploaded to CENTRAL was included for the following journals:   
 American Journal of Orthodontics and Dentofacial Orthopedics 
 The Angle Orthodontist 
 European Journal of Orthodontics 
 Journal of Orthodontics 
 Seminars in Orthodontics 
 Clinical Orthodontics and Research 
 Australian Journal of Orthodontics 
 Journal of Clinical Orthodontics 
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The bibliographies of the clinical trials identified were checked for references to trials 
published outside the handsearched journals. 
Personal references were checked. 
 
3.2.2.3 Language 
Databases were searched to include all languages and non-English language papers were 
translated. 
 
3.2.2.4 Unpublished Studies 
The first authors of all trial reports were contacted in an attempt to identify unpublished 
studies and to obtain any further information about the trials. In addition, trial registries were 
searched to identify on-going studies. These included www.clinicaltrials.gov, clinicaltrials-
dev.ifpma.org, and isrctn.org. 
 
3.2.3 Data Collection and Analysis 
 
3.2.3.1 Study Selection 
 The titles and abstracts of the search results were examined to remove obviously 
irrelevant reports, being generally over inclusive at this stage. This was done by two 
review authors (from Simon Watkinson (SW), Jayne Harrison (JH) or Sue Furness 
(SF)) independently and in duplicate. Disagreements would have been resolved by 
discussion between these review authors. If arbitration was required, it would have 
been provided by Annabel Teague (AT). 
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 Full text reports of potentially eligible studies were examined for compliance with the 
eligibility criteria. This was performed by two review authors (from SW, JH or SF) 
independently and in duplicate. We corresponded with investigators, where 
appropriate, to clarify study eligibility. Disagreements would have been resolved by 
discussion between these review authors. If arbitration was required, it would have 
been provided by AT. If additional information was required, the corresponding 
author of the trial was contacted and the study categorised as one awaiting 
assessment. Study eligibility was performed with the aid of a piloted study eligibility 
form. 
 A list of excluded studies was recorded giving the primary reason for exclusion 
following the screening of the titles and abstracts stage. 
 
3.2.3.2 Data Extraction 
Data extraction was performed independently and in duplicate by two review authors (from 
SW, JH and SF). A piloted data extraction form was used independently to record the year of 
publication, interventions assessed, outcomes, sample size and age of the subjects. The 
primary outcome was the prominence of the lower front teeth and the secondary outcomes 
were the relationship between the upper and lower jaws, psychosocial outcomes and patient 
satisfaction and jaw joint problems. Other outcomes were recorded for descriptive purposes 
e.g. relationship of the upper jaw (Sella-Nasion-A point), relationship of the lower jaw (Sella-
Nasion- B point), and incisor angle to the lower jaw. Adverse effects, e.g. health of the gums, 
damage to the teeth e.g. tooth decay, would have been recorded and the results reported in 
descriptive terms. 
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Outcome data would have been grouped into those measured post phase I (growth 
modification phase) and post phase II (fixed brace phase) and, where available, post-retention 
outcomes would be recorded and reported. If outcome data were recorded at other time 
points, consideration would have been given to recording these as well. 
 
3.2.3.3 Assessment of risk of bias in included studies 
The Cochrane risk of bias tool was used to assess the methodological quality of the studies. 
This was undertaken independently and in duplicate by two review authors (from SW, JH or 
SF) as a part of the data extraction process. Six specific domains were investigated: sequence 
generation; allocation concealment; blinding of participants; personnel and outcome 
assessors; incomplete outcome data; selective outcome reporting and ‘other sources of bias’. 
Each domain was given a judgement that could be high, low or unclear. 'High' indicated and 
high risk of bias, 'Low' a low risk of bias and ’Unclear’ indicated an unclear or unknown 
level of bias. The risk of bias tool was undertaken as described in the Cochrane Handbook for 
Systematic Reviews of Interventions. Sequence generation was assessed for the study as a 
whole. Blinding, incomplete outcome data and selective outcome reporting were assessed on 
the level of the study and for each outcome as appropriate. 
 
3.2.3.4 Measures of Treatment Effect 
The Cochrane Collaboration statistical guidelines were followed and the data analysed using 
RevMan and reported according to Cochrane Collaboration criteria. 
 
For dichotomous data, the estimates of effect of an intervention would have been expressed 
as risk ratios together with 95% confidence intervals. 
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For continuous outcomes, mean differences and 95% confidence intervals were used to 
summarise the data for each group where the mean difference and standard deviations were 
calculable from the data presented. 
 
3.2.3.5 Dealing with Missing Data 
If there were any missing data, an attempt was made to contact the original trial investigators. 
A study was not excluded from the review because of missing summary data, however the 
potential implications of its absence from any meta-analysis were discussed. 
 
3.2.3.6 Assessment of Heterogeneity 
Clinical heterogeneity was assessed by examining the type of participants, interventions and 
outcomes in each study. Meta-analysis was only used when studies of similar comparisons 
were reporting comparable outcome measures. A random-effects model was planned for use 
for all analysis with more than three studies, otherwise a fixed-effect model was used. I
2
 
statistics were used as measures of statistical heterogeneity. 
 
3.2.3.7 Assessment of Reporting Biases 
Only a proportion of research projects conducted are ultimately published in an indexed 
journal and become easily identifiable for inclusion in systematic reviews.  Reporting biases 
arise when the reporting of research findings is influenced by the nature and direction of the 
findings of the research.
102
 We investigated and attempted to minimise potential reporting 
biases including publication bias, multiple (duplicate) publication bias and language bias in 
this review. 
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If there were more than ten studies in one outcome we planned to construct a funnel plot. If 
there was asymmetry in the funnel plot, indicating possible publication bias, we planned to 
undertake statistical analysis using the methods introduced by Egger (continuous outcome) 
and Rücker (dichotomous outcome).
103, 104
 Insufficient studies were identified to investigate 
reporting biases. 
 
3.2.3.8 Data Synthesis 
A random-effects meta-analysis, using the inverse variance method, was planned for use for 
all primary and secondary outcomes for all analyses with more than three studies. Studies of 
each intervention were analysed and presented separately. 
A general framework for data synthesis was used to report the adverse effects. The following 
questions were considered when analysing these effects: 
 What was the size of the effect? 
 Was the effect consistent across studies? 
 What was the strength of evidence for the effect? 
 
3.2.3.9 Subgroup analysis and investigation of heterogeneity   
We planned to investigate clinical heterogeneity by examining: the nature of the 
interventions; ages; background and number of participants and reported outcomes. No 
subgroup analyses were planned. 
 
44 
 
3.2.3.10 Sensitivity analysis 
Providing there were sufficient studies for each intervention and outcome, we planned to 
undertake sensitivity analysis based on risk of bias (including low risk of bias studies only). 
 
3.2.3.11 Presentation of main results 
A summary of findings table was developed for the primary outcomes of this review using 
GRADEPro software.  The quality of the body of evidence was assessed with reference to the 
overall risk of bias of the included studies; the directness of the evidence; the inconsistency 
of the results; the precision of the estimates; the risk of publication bias and the magnitude of 
the effect. The quality of the body of evidence for each of the primary outcomes was 
categorised as high, moderate, low or very low and summary of findings tables have been 
produced for the main outcomes of this review. 
 
 
 
 
 
 
Chapter 4: Results 
4.1 Description of Studies 
4.1.1 Results of the search   
The database search found 440 articles. Of these 19 were duplicates. Of the remaining 421, 
391 were discarded during the screening of the titles and abstracts. Of the remaining 30 
articles, for which the full text was examined, 22 were excluded leaving 8 included articles, 2 
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of which were reporting the outcomes of the same study, at different time points, leaving 7 
randomised controlled trials to be included in this review. (Figure 11) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
440 records identified through database 
searching  
421 records after duplicates removed 
421 records screened 391 records excluded 
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Figure 11: Study flow diagram 
4.1.2 Included studies   
Seven trials were included in this review (see Table 2). All trials were parallel randomised 
controlled trials. Three trials were conducted in Turkey,
87, 105, 106
 one in Egypt,
33
 one in the 
United Kingdom,
72, 107
 one in the United States of America,
81
 and one in China.
108
 Six trials 
reported outcome data solely immediately post treatment. One trial had outcomes reported at 
both 15 months and 3 years after the start of treatment.
107
 (see Appendix 5) 
 
4.1.2.1 Characteristics of the trial setting and investigators 
All of the included trials were conducted in college/university orthodontic departments. Six 
of the trials were carried out in a single institution,
33, 81, 87, 105, 106, 108
 one in 8 centres in the 
same country.
72, 107 
30 full-text articles assessed for eligibility 
7 trials (2 articles reporting the same study) 
included in the qualitative synthesis 
7 trials included in quantitative synthesis 
(meta-analysis) 
22 records excluded 
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Orthodontists provided the care for the children in all the trials. Only one paper stated they 
had 2 operators,
81
 the remainder did not disclose the number of operators. 
 
Only one trial disclosed external funding.
72, 107 
4.1.2.2 Characteristics of the participants 
All trials were conducted on children aged between 5 and 11 years. They were from different 
ethnic backgrounds, dependant on the trial setting. There were between 20
105
 and 73
72 
children included in the 7 trials, with a median of 46. Approximately equal numbers of boys 
and girls were included in each trial. 
4.1.2.3 Characteristics of the interventions 
Four different types of intervention and an untreated control group were compared in the 7 
included trials. The comparisons were: 
 Facemask versus Untreated Control72, 81, 107, 108  
 Facemask with expansion versus Facemask only81 
 Nanda facemask versus Conventional facemask105 
 600g Chin cup versus 300g Chin cup versus Untreated Control33 
 Tandem traction bow appliance versus Untreated Control87 
 Mandibular headgear versus Chin cup versus Untreated Control106 
Characteristics of the outcomes 
Five outcomes were presented in the results for the 7 included trials. 
 Overjet72, 87, 107  
 ANB33, 72, 81, 87, 105-108  
 Wits appraisal33, 81 
 Piers Harris children's self-concept scale72, 107 
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 Oral Aesthetic Subjective Impact Score (OASIS)72, 107 
 
 
 
 
 
 
 
Study Country Interventions Number of 
participants 
Outcomes 
measured 
Abdelnaby and 
Nasser
33 
Egypt 300g chin cup 
600g chin cup 
Untreated control 
50 ANB 
Wits 
Arun et al.
106 
Turkey Mandibular headgear 
Chin cup 
Untreated control 
60 ANB 
Atalay and 
Tortop
87 
Turkey TTBA 
Untreated control 
30 Overjet  
ANB 
Keles et al.
105 
Turkey Nanda facemask 
Conventional facemask 
20 ANB 
Mandall et al.
72, 
107 
UK Facemask 
Untreated control 
73 Overjet 
ANB 
Piers Harris 
children's self-
concept scale 
OASIS 
Vaughn et al.
81 
USA Facemask with 
expansion 
Facemask without 
expansion 
46 ANB 
Wits 
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Xu
108 
China Facemask 
Untreated control 
60 ANB 
 
Table 2: Summary of characteristics of included trials 
 
 
 
 
 
4.1.3 Excluded studies   
A reason for exclusion of each trial of which the full text was assessed is given in Appendix 
6. Of the 22 excluded studies: 
 13 were excluded as they were not RCTs 
 6 used retrospective control groups 
 1 was entirely retrospective 
 1 did not report an outcome of interest to this review 
 1 reported outcomes for patients over age 16. 
4.2 Risk of bias in included studies 
The risk of bias assessment for each trial can be found in Appendix 7. 
4.2.1 Allocation (selection bias)   
4.2.1.1 Sequence Generation 
Sequence generation was adequate for four of the trials
72, 81, 87, 106, 107
 and unclear for the 
remaining trials. Whilst the Arun et al.
106
 and Atalay and Tortop
87
 papers were unclear in the 
text, contact with the authors revealed the use of a random number generator for patient 
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assignment on registration to the trial. Mandall et al.
72, 107
 used randomisation blocks of 10 
with stratification according to gender and a computer generated randomisation sequence. 
Vaughn et al.
81
 also used a block randomisation table to assign to one of the 3 groups. The 
remaining papers did not mention how a sequence was generated and no response has been 
received from the authors for further clarification. 
4.2.1.2 Allocation concealment 
Allocation concealment was adequate in only the Mandall et al. trial,
72, 107
 using a sequence 
that was concealed centrally and each clinician telephoned the research assistant for 
allocation once the patient was registered. It was unclear for four of the trials,
33, 81, 105, 108
  in 
which there was no mention of allocation concealment in the articles and there has been no 
response from the authors to clarify. There was a high risk of bias from the remaining two 
articles with whom contact was made and they disclosed that no allocation concealment was 
used.
87, 106 
4.2.2 Blinding (performance bias and detection bias)   
The blinding of participants would not have been possible in 6 of the 7 trials due to the nature 
of the treatments in comparison with other treatments and the untreated controls. However, it 
may have been possible to blind patients in the Abdelnaby and Nassar trial that compared the 
strength of force of the chin cups.
33
 No mention of an attempt to do this was mentioned in the 
paper and the author has not responded to clarify the situation. 
The blinding of the personnel taking part in the trials would not have been possible due to the 
nature of the treatments being used. 
The blinding of the outcome assessment would have been possible in all cases as 
cephalometric measures were used as outcomes in all trials. There was a low risk of bias in 
the Mandall et al. trial in which the researchers measuring the radiographs and study models, 
as well as the statistician, were all blinded.
72
 There was also low risk of bias in the Vaughn et 
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al. trial as the principal investigator carrying out the analysis was blinded to the patient 
assignment.
81
 The blinding of outcome assessment was unclear in the Abdelnaby and Nassar, 
Keles et al. and Xu  trials in which no mention of blinding was made and no response from 
the authors has been received to clarify.
33, 105, 108
 The authors of the Arun et al. and Atalay and 
Tortop trials confirmed that there were no attempts at blinding at any stage in these trials and 
therefore the risk of bias is high.
87, 106 
 
4.2.3 Incomplete outcome data (attrition bias)   
There was a low risk of attrition bias for the Arun et al., Atalay and Tortop, Mandall et al. 
and Xu trials as the participants included in the analysis are exactly those randomised in the 
trial.
72, 87, 106, 107, 108
 The number of dropouts in the remaining three trials is unclear and the 
authors have not responded to clarify, so the risk of attrition bias in these trials was assessed 
as unclear.
33, 81, 105 
 
4.2.4 Selective reporting (reporting bias)   
There is a low risk of reporting bias for all trials. All trials reported on the outcomes that they 
set out to report and there were no obvious anomalies. 
 
4.2.5 Other potential sources of bias   
The Abdelnaby and Nassar trial states that the groups are randomly allocated yet has 20 
patients in groups 1 and 2 and only 10 in group 3.
33
 Clarification on the exact method of 
randomisation has not been possible as the author has not responded to contact, however this 
leads to an assumption of high risk of bias. 
The authors of the Arun et al. and Atalay and Tortop trials have clarified all our questions 
regarding other bias, and have been assessed at low risk of other bias.
87, 106  
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The Mandall et al. paper disclosed that some patients included in this trial had a centric 
relation to centric occlusion displacement.
72, 107
 This may have influenced the perception of 
the skeletal discrepancy from the lateral cephalogram. The actual effects of this on the results 
are uncertain. Randomisation of groups, which was carried out adequately, should have 
minimised any bias introduced by this and therefore the study has still been graded as being 
of low risk of bias. 
There are no other obvious potential sources of bias for the Keles et al. or Vaughn et al. 
trials.
81, 105 
 
4.2.6 Overall risk of bias 
The trial by Mandall et al. shows overall low risk of bias.
72, 107
 Three trials are assessed at 
high risk of bias due to the absence of allocation concealment and blinding of outcome 
assessment (Arun et al. and Atalay and Tortop) and inadequate randomisation (Abdelnaby 
and Nassar).
33, 87, 106
 The remaining three trials (Keles et al., Vaughn et al. and Xu) are 
assessed as unclear risk of bias.
81, 105, 108 
These conclusions can be seen in Figures 13 and 14.  
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Figure 13: Risk of bias graph: review authors' judgements about each risk of bias item 
presented as percentages across all included trials. 
 
Figure 14: Risk of bias summary: review authors' judgements about each risk of bias item for 
each included trial. 
4.3 Effects of interventions   
There were 8 comparisons in the 7 included trials. The results for each comparison are 
summarised below. All data and analysis tables can be found in Appendix 8 (Tables 3-11, 
Figure 15).  
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4.3.1 Facemask versus Untreated control 
Three trials investigated the use of a facemask versus an untreated control (Mandall et al., 
Vaughn et al. and Xu).
72, 81, 107, 108
 I have combined the results from the trial using the 
facemask with and without rapid maxillary expansion as they showed no statistical difference 
(see later).
81
 The only outcome considered by all three trials was ANB. The Mandall et al. 
trial also assessed overjet and self-concept measures whilst Vaughn et al. also assessed Wits 
appraisal (another measure of the relative positions of the maxilla and mandible).
72, 81, 107
 The 
Mandall et al. trial reported outcomes at the end of treatment and at 3 years’ follow-up.72, 107 
(See Tables 3, 4) 
 
4.3.1.1 Overjet 
The Mandall et al. trial was the only one that reported overjet and found a statistically 
significant difference of 4.10 mm (95%CI 3.04 to 5.16; P<0.0001) in favour of the facemask 
post-treatment.
72, 107
 They also found a statistically significant difference of 2.50 mm (95%CI 
1.21 to 3.79; P=0.0001) at 3 years’ follow-up.107 
 
4.3.1.2 ANB 
Three trials included the outcome ANB (Mandall et al., Vaughn et al. and Xu),
72, 81, 107, 108
 and 
it was possible to undertake a meta-analysis at the post-treatment stage. The pooled estimate 
was 3.93 degrees (95% CI 3.46 to 4.39; P<0.0001) in favour of the facemask. There was 
substantial heterogeneity (P=0.004; I
2
=82%) between the trials which may be due to several 
factors including: different inclusion criteria, different ethnic groups, different populations 
and different ages of the patients at the start of treatment. However, each trial demonstrated a 
statistically significant benefit for the facemask and we thought it appropriate to pool the 
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results. The random effects model gave rise to a similar estimate of 3.70 degrees (95%CI 2.50 
to 4.91; P<0.0001). (See Figure 15) 
The Mandall at al. trial assessed ANB at 3 years’ follow-up and found that the statistically 
significant benefit of 1.4 degrees (95%CI 0.43 to 2.37; P=0.004) persisted in favour of the 
facemask.
107 
 
4.3.1.3 Wits appraisal 
The Vaughn et al. trial looked at Wits and showed a benefit in favour of the facemask of -
3.84 mm (95%CI -5.31 to -2.37; P<0.0001).
81 
 
4.3.1.4 Psychosocial Outcomes 
There was no difference between the facemask and untreated control groups in the Mandall et 
al. trial in the outcome of self-concept measured on the Piers-Harris self-concept index at 
either the post-treatment or 3 year follow-up time points.
72, 107 
The OASIS assessment of oral self-perception, however, did demonstrate a statistically 
significant benefit for the facemask at the post-treatment stage of -4.00 (95%CI -7.40 to -
0.60; P=0.02). However, there was no significant difference at 3 years’ follow-up: -3.40 
(95%CI -7.99 to 1.19; P=0.15).
72, 107 
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4.3.1.5 Adverse Effects 
Only the Mandall et al. trial reported on temporomandibular joint (TMJ) signs and symptoms. 
It noted that due to low prevalence of TMJ signs and symptoms at all time points no 
statistical analysis was carried out.
72, 107 
 
4.3.2 Facemask with expansion versus Facemask only 
The Vaughn et al. trial compared the facemask with and without expansion.
81
 There was no 
evidence of a difference between treatment using a facemask with or without the use of rapid 
maxillary expansion for the outcomes of ANB (-0.13 degrees (95%CI -1.40 to 1.14; P=0.84)) 
and Wits (-0.16 mm ((95%CI -1.63 to 1.31; P=0.83)). (See Tables 3, 5)  
 
4.3.3 Nanda facemask versus Conventional facemask 
The Keles et al. trial compared Nanda facemask versus Conventional facemask.
105
 There was 
weak evidence of a difference in ANB between the groups using each design of facemask in 
favour of the Nanda facemask: 1.29 degrees (95%CI 0.16 to 2.42; P=0.02). (See Tables 3, 6)  
 
4.3.4 Chin cup (600g and 300g) versus Control, and 600g vs 300g 
The Abdelnaby and Nassar trial compared 600g and 300g chin cup with an untreated control 
group in a three arm trial.
33
 Both chin cup groups had improved ANB and Wits when 
compared to the untreated control: 
 600g ANB 2.00 degrees (95% CI 1.61 to 2.39; P<0.001)  
 300g ANB 1.90 degrees (95%CI 1.43 to 2.37; P<0.001)  
 600g Wits 4.80 mm (95%CI 4.13 to 5.47; P<0.0001)  
 300g Wits 5.10 mm (95%CI 4.43 to 5.77; P<0.0001)  
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With respect to 600g versus 300g chin cup there was no difference in ANB (0.10 degrees 
(95%CI -0.31 to 0.51; P=0.63)) or Wits (-0.30 mm (95%CI -1.12 to 0.52; P=0.47)). (See 
Tables 3, 7, 8, 9) 
 
4.3.5 Tandem traction bow appliance versus Untreated control 
The Atalay and Tortop trial compared Tandem traction bow appliance with an untreated 
control.
87 
Two outcomes, overjet and ANB were reported and both demonstrated a 
statistically significant benefit in favour of the Tandem traction bow appliance. Overjet 3.30 
mm (95%CI 2.46 to 4.14 P<0.0001); ANB 1.70 degrees (95%CI 1.09 to 2.31; P<0.0001). 
(See Tables 3, 10)  
 
4.3.6 Mandibular headgear versus Chin cup versus Untreated control 
The Arun et al. trial compared mandibular headgear or a chin cup with an untreated 
control.
106 
It provided outcome data for ANB, however no standard deviations were given and 
P-values from the Mann Whitney test were presented, so I was unable to use the data. Both 
mandibular headgear and chin cup showed statistically significant benefit for ANB compared 
to the control P<0.001; however, there was no statistically significant difference between the 
two active interventions (P>0.05). (See Table 11) 
 
 
 
 
Chapter 5: Discussion 
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5.1 Summary of main results   
5.1.1 Facemask Therapy 
There was some evidence that facemask therapy was more effective at improving overjet, 
ANB and Wits appraisal immediately post treatment when compared with an untreated 
control. The improvements in overjet and Wits were still statistically significant at 3 years’ 
follow-up, although reduced in comparison to the changes immediately post-treatment. These 
changes can still be considered to be of clinical significance. Whilst immediately following 
treatment there was a statistically significant improvement in the OASIS score, there was no 
evidence that facemask treatment produced clinically important changes in patients' self-
concept or self-perception measures. 
There was insufficient evidence to determine whether there was a difference between the 
outcomes reported in a comparison between facemask with and without the use of rapid 
maxillary expansion from the single small trial which evaluated this comparison. Therefore, 
its use solely as an adjunct to improve the efficacy of facemask therapy, can not be 
recommended. 
One trial compared the use of a Nanda facemask (force applied at parallel to the Frankfort 
plane at a level 20mm above the occlusal plane) with a conventional facemask (force applied 
at 30 degrees at the level of the occlusal plane).
105
 This very small trial showed weak 
evidence of a difference in ANB between the two appliances in favour of the Nanda 
facemask, however due to the size of the trial and its risk of bias no recommendation can be 
made to support one design over the other. 
The ultimate aim of facemask treatment is to correct the jaw discrepancy at an early stage so 
reducing the need for any orthognathic surgical intervention at a later stage. It must be noted 
that only one published trial has reported data beyond the end of orthodontic treatment,
107
 and 
this only at 3 years’ follow-up, so no evidence was found for a long term benefit for facemask 
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therapy beyond 3 years. Discussion with the authors of this trial has revealed that the trial is 
on-going. The final report of this trial is due for publication in the near future and we hope it 
will be included in future issues of this review. For ethical reasons there is a limit as to how 
long treatment can be withheld from a patient and, therefore, a limit as to how long term a 
trial of this nature can be followed up. We hope that the final results of the trial will give us 
an indication as to what percentage of patients avoided a surgical intervention to correct their 
malocclusion due to the early intervention with the facemask. 
The papers by Mandall et al. were overall of low risk of bias, however, one potential area for 
bias was noted.
72, 107
 Some of the patients had a displacement from centric relation into 
maximum intercuspation. The lateral cephalograms and overjet measurements were taken in 
maximum intercuspation. Therefore, this may have made the pre-treatment overjet and ANB 
appear worse than was actually the case, so influencing the results. Whilst the overall impact 
of this on the results is unclear it must be considered a potential source of bias in the trial 
design. 
Only one trial reported on adverse effects and showed no changes in TMJ signs and 
symptoms as a result of facemask therapy.
72 
 
5.1.2 Chin cup Therapy 
There were two trials showing evidence that the use of a chin cup led to statistically 
significant benefit in ANB when compared to an untreated control.
33, 106
 A meta-analysis was 
not possible due to missing data from one trial.
106 
Again, the trials were short-term and there 
was no evidence of any long term benefit.  
There was no statistically significant difference found between the use of 300g and 600g 
force when used with the chin cup. 
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These trials were of high risk of bias and as such their results should be interpreted with 
caution. At this stage the authors are unable to recommend the use of the chin cup for early 
correction of a Class III malocclusion. 
 
5.1.3 Tandem Traction Bow Appliance (TTBA) 
One trial reported results on the use of the TTBA when compared with an untreated control.
87
 
It showed that there was a statistically significant benefit in favour of the TTBA. Again, the 
trial was short term and there was no evidence for long term benefit. In addition, the trial was 
of high risk of bias and therefore even the short term results should be interpreted with 
caution. 
 
5.1.4 Mandibular Headgear 
One trial reported results on the use of mandibular headgear compared to an untreated control 
and the chin cup.
106
 Statistical analysis was not possible due to missing data, however, it was 
reported that there was significant benefit in favour of the mandibular headgear with respect 
to ANB when compared to the untreated control. There was no statistically significant 
difference between the mandibular headgear and the chin cup. In addition, this trial was of 
high risk of bias and therefore all results should be interpreted with caution. 
 
5.2 Overall completeness and applicability of evidence   
Overall, seven trials were found investigating multiple comparisons to treat Class III incisors 
in children and adolescents and reported multiple outcomes. Four of the trials investigated the 
facemask, two the chin cup, one TTBA and one mandibular headgear. Only one investigated 
beyond the treatment phase and that only at 3 years’ follow-up. This has major implications 
61 
 
for the applicability of the evidence. An aim of early intervention for a Class III malocclusion 
is to prevent subsequent need for corrective orthognathic surgery. The current evidence does 
not allow us to assess if any of the interventions have succeeded in this aim, due to their short 
term nature. 
The concern of many patients seeking treatment for a Class III malocclusion is that their 
lower front teeth meet in front of their upper front teeth and therefore they have a reverse 
overjet. The patients are unaware of their cephalometric measurements and the use solely of 
these measures does not allow adequate assessment of patient-centred outcomes. However, 
only two of the trials reported overjet as an outcome.
72, 87 
This must be considered a 
significant flaw in the current evidence. Whilst cephalometric measurements can be useful 
indicators for clinical benefit, they mean little to a patient. Large changes in a patients ANB 
or Wits appraisal do not necessarily mean that the treatment outcome has been successful. 
Future research must aim to report outcomes of interest to patients. I therefore recommend a 
much greater use of patient-centred outcomes and patient satisfaction measurements, with 
less emphasis on the use of cephalometric measurements as primary outcomes. 
The use of a sample size calculation allows the researcher to be sure that there is sufficient 
power in the trial design that if a true difference exists then the trial should detect it. It can 
prevent the waste of research resources and also prevent undue inclusion of excessive patient 
numbers which may be considered unethical. Only one trial carried out a sample size 
calculation,
72, 107
 and it is possible that the Vaughn et al. trial was underpowered to find a 
difference between their facemask groups.
81 
 
The lack of accurate reporting, especially with respect to unclear methodology, and in one 
case, missing statistical data, means much of the evidence was of low or very low quality and 
overall the results must be interpreted with caution. 
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5.3 Quality of the evidence   
The overall quality of the evidence can be seen in the Summary of Findings tables (Tables 
12, 13, 14) 
The evidence regarding overjet and ANB changes, when comparing the use of a facemask 
with an untreated control, has been graded as moderate. This implies that further research is 
likely to have an important impact on our confidence in the estimate of effect and may 
change the estimate but is unlikely to overturn the direction of the effect. 
All other comparisons and outcomes have been graded as a low or very low level of 
evidence. The reasons for this are the low number of trials and participants, the unclear or 
high risk of bias in these trials and in the meta-analysis, the high level of heterogeneity. 
5.4 Potential biases in the review process   
The manner in which a Cochrane systematic review is undertaken minimises the risk of bias 
being introduced into the review. Bias has been reduced in this systematic review by using a 
broad sensitive search of multiple databases with no restrictions on language. We have also 
searched for unpublished studies and data, and included studies reported in all languages 
(involving the translation of one Chinese paper and several Turkish papers).  
5.5 Agreements and disagreements with other studies or reviews 
Five other reviews were found that reported on similar comparisons and outcomes to this 
study.
83, 109, 110, 111, 112
 
de Toffol et al., Jager et al. and Kim et al. all report with greater confidence the efficacy of 
the facemask than we have reported.
83, 109, 111
 The difference in confidence is due to the 
greater number of studies that the other systematic reviews have included. This discrepancy is 
due to the differing inclusion criteria used in our systematic review when compared to the 
previous reviews. We have only included prospective randomised controlled trials, whilst the 
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other reviews have included retrospective studies. This is inherent in the methodology used in 
a Cochrane systematic review when compared with other reviews. Whilst the inclusion of a 
greater number of studies and, therefore, a greater number of participants allows a more 
powerful result to be produced it inevitably allows a much greater influence of bias. 
Therefore, the results of this systematic review are more reliable than those that were carried 
out previously. From the results that we have obtained only the paper by de Toffel et al. has 
included any of the studies on facemasks that we have included.
109 
 
The review by Kim et al. supports the use of rapid maxillary expansion prior to facemask 
therapy, whilst we have found insufficient evidence to support this protocol.
83
 Again, the 
difference is due to the inclusion of retrospective studies in the previous review. Only one 
randomised controlled trial has been carried out in this area and this showed no significant 
differences.
81 
The recommendations made by Kim et al. were based on two retrospective 
studies. 
 
Liu et al. reports on the efficacy of the chin cup appliance and agrees with our conclusion that 
there are insufficient data in the current trials to make clear recommendations regarding the 
efficacy of chin cup therapy.
112 
This review, whilst allowing controlled clinical studies and 
cohort studies, was closer in nature to a Cochrane systematic review and therefore explains 
why the results in this area were similar. 
 
5.6 Implications for practice 
At the current stage there is insufficient evidence to recommend the use of chin cups, 
mandibular headgear or the TTBA. There is evidence that the use of a facemask produces 
short term improvements in overjet and ANB. However, the aim of early interventions may 
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be considered two-fold. Firstly, they aim to correct the presenting malocclusion in an attempt 
to reduce the need for later intervention, which in this case will usually involve the use of 
orthognathic surgery. Whilst the evidence thus far suggests that they are effective at 
correcting the presenting Class III malocclusion, it does not allow us to know whether the use 
of the facemask reduces the need for later intervention. It is hoped that the results of the on-
going trial by Mandall et al., combined with future research, may allow a greater 
understanding of the effectiveness of the facemask at reducing later surgery. Secondly, early 
intervention may reduce the psychosocial impact of the malocclusion. If the child is being 
teased or bullied due to their malocclusion it would be hoped that if there is an early 
intervention to reduce this malocclusion, the teasing and bullying will be reduced and 
therefore psychosocial measures will be improved. The evidence from the only trial using 
these measures suggests that up to 3 years after treatment this is not the case.
107 
Therefore, at 
this time, early intervention in order to improve the psychosocial impact of the malocclusion, 
can not be recommended. 
 
5.7 Implications for Research 
This review has shown that there is only one trial in this field that has been carried out with 
an overall low risk of bias, and there was possible methodological bias even with this trial, 
due to the inclusion of children with a displacement from centric relation to maximum 
intercuspation. In order for clinicians to be carrying out sound evidence based treatments, the 
evidence should be of the highest standard. Therefore, there needs to be considerably more 
research carried out in this field, and that research should be carried out to a much higher 
standard than the majority of existing studies have been. 
When designing future trials, the following need to be considered: 
 Clear inclusion and exclusion criteria should be set. 
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 An a priori sample size calculation should be carried out. 
 The use of outcomes relevant to the patient (not solely a list of cephalometric 
measures) should be used. The following are recommended: 
o Overjet  
o Overjet change. 
o Correction of an anterior crossbite. 
o ANB. 
o Psychosocial measures. 
 The following methodological points are recommended: 
o Recording if there is a discrepancy between centric relation and maximum 
intercuspation. 
o All lateral cephalograms should be taken in the centric relation. 
 Adverse effects should be reported 
 Long term follow-up, to assess fully if the treatment has been successful at the end of 
growth, should be considered. 
Reports on clinical trials would be improved by following the guidelines produced by the 
CONSORT Group to ensure that all relevant information is provided.
113 
If these recommendations are followed it will allow much more reliable conclusions to be 
drawn in future issues of this review and therefore allow clinicians to base their treatment 
decisions on much greater evidence base. 
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Chapter 6: Conclusions 
6.1 Overall Conclusions 
There is some evidence that the use of facemask therapy, between the ages of 6-10 years, 
leads to short term improvements in overjet and ANB. These improvements have been 
shown, in high level evidence, to be maintained until 3 years after treatment.  
There is insufficient evidence to support the use of any other intervention for the early 
treatment of a child with Class III incisors. 
There is insufficient long term evidence to fully understand the benefit of early intervention 
for a patient with Class III incisors. 
 
6.2 Implications for practice   
There is some evidence to support the use of the facemask for early treatment of Class III 
incisors. The long term benefits, however, are still unknown. 
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There is insufficient evidence to support the use of any other appliance for early treatment of 
Class III incisors. 
 
6.3 Implications and recommendations for research   
In view of the quality of the trials identified in this systematic review, it has been difficult to 
draw definitive conclusions. This review suggests the need for more long term, well designed 
and reported randomised controlled clinical trials to assess the efficacy of early orthodontic 
treatment for prominent lower front teeth. When designing future trials, consideration should 
be given to use of the recommendations made in the discussion. 
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Appendix 1: Cochrane Oral Health Group 
Trials Register Search Strategy   
 
A search was undertaken using the Cochrane Register of Studies and the search strategy 
below: 
 
 #1        ("prominent lower front teeth" or underbite* or under-bite* or "under bite*" or 
reverse-bite* or "reverse bite*" or prognath* or "Malocclusion Angle Class III" or "Angle* 
class III") AND (INREGISTER) 
#2         (("Class III" AND (malocclusion or bite))) AND (INREGISTER) 
#3        (#1 or #2) AND (INREGISTER) 
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#4        (("orthodontic appliance*" OR "orthodontic device*" OR "removable appliance*" OR 
"removable device*" OR "functional appliance*" OR "functional device*" OR "fixed 
appliance*" OR "growth modif*" or brace* OR ((extraoral OR "extra oral" or extra-oral) 
AND traction) OR "chin cap*" or chin-cap* or chincap* OR "chin cup*" or chin-cup* or 
chincup* or "face mask*" OR facemask* or face-mask* OR "reverse head gear" OR "reverse 
head-gear")) AND (INREGISTER) 
#5        (((orthopedic* OR orthopaedic*) AND (dental OR orthodontic* OR facial))) AND 
(INREGISTER) 
#6        (#4 or #5) AND (INREGISTER) 
#7        (#3 AND #6) AND (INREGISTER) 
 
 A previous search of the Register was undertaken in July 2011 using the Procite software 
and the search strategy below: 
 
(("prominent lower front teeth" or underbite* or under-bite* or "under bite*" or reverse-bite* 
or "reverse bite*" or prognath* or "Malocclusion Angle Class III" OR "Angle* class III" OR 
("Class III" AND (malocclusion* OR bite))) AND ("orthodontic appliance*" OR 
"orthodontic device*" OR "removable appliance*" OR "removable device*" OR "functional 
appliance*" OR "functional device*" OR "fixed appliance*" OR "growth modif*" or brace* 
OR ((extraoral OR "extra oral" or extra-oral) AND traction) OR "chin cap*" or chin-cap* or 
chincap* OR "chin cup*" or chin-cup* or chincup* or "face mask*" OR facemask* or face-
mask* OR "reverse head gear" OR "reverse head-gear" OR ((orthopedic* OR orthopaedic*) 
AND (dental OR orthodontic* OR facial)))) 
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Appendix 2: Cochrane Central Register of 
Controlled Trials (CENTRAL) Search 
Strategy   
 
#1        MeSH descriptor Malocclusion, Angle Class III 
#2        ("Class III" in All Text and (Angle in All Text or Angle's in All Text or 
malocclusion* in All Text or bite* in All Text))                        
#3        (underbite* in All Text or under-bite* in All Text or "under bite*" in All Text or 
"reverse bite*" in All Text or reverse-bite* in All Text or prognath* in All Text)        
 #4        "prominent lower front teeth” 
#5        (#1 or #2 or #3 or #4) 
#6        MeSH descriptor Orthodontic Appliances, Functional explode all trees   
 #7        MeSH descriptor Orthodontic Appliances, Removable explode all trees 
85 
 
#8        ("growth modif*" in All Text and (jaw in All Text or maxilla* in All Text or 
mandible in All Text)) 
#9        (("fixed appliance*" in All Text or brace* in All Text) and orthodontic* in All Text) 
#10      ((extraoral in All Text or extra-oral in All Text or "extra oral" in All Text) and 
traction in All Text) 
#11      ("chin cap*" in All Text or chin-cap* in All Text or chincap* in All Text) 
#12      (("face mask*" in All Text or face-mask* in All Text or facemask* in All Text or 
"reverse head-gear" in All Text or "reverse headgear" in All Text) and orthodontic* in All 
Text) 
#13      ((orthopedic* in All Text or orthopaedic* in All Text) and (dental in All Text or 
orthodontic* in All Text or facial in All Text)) 
#14      (#6 or #7 or #8 or #9 or #10 or #11 or #12 or #13)     
#15      (#5 and #14) 
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Appendix 3: MEDLINE (OVID) Search 
Strategy   
 
1. Malocclusion, Angle Class III/            
2.        ("Class III" and (Angle or Angle's or malocclusion$ or bite$)).mp.    
3.         (underbite$ or under-bite$ or "under bite$" or "reverse bite$" or reverse-bite$ or 
prognath$).mp.                                 
4.         "prominent lower front teeth".mp.                               
5.         or/1-4                           
6.         exp Orthodontic Appliances, Functional/                                
7.         exp Orthodontic Appliances, Removable/                              
8.         ("growth modif$" and (jaw or maxilla$ or mandible)).mp.                  
9.         (("fixed appliance$" or brace$) and orthodontic$).mp.                                  
10.       ((extraoral or extra-oral) and traction).mp. 
11.       "chin cap$".mp.                       
87 
 
12.       (("face mask$" or facemask$ or face-mask$ or "reverse head-gear" or "reverse 
headgear") and orthodontic$).mp. 
13.       ((orthopedic$ or orthopaedic$) and (dental or orthodontic$ or facial)).mp.   
14.       or/6-13                                     
15.       5 and 14 
 
The above subject search was linked to the Cochrane Highly Sensitive Search Strategy 
(CHSSS) for identifying randomized trials in MEDLINE: sensitivity maximising version 
(2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of The Cochrane 
Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. 
 
1. randomized controlled trial.pt. 
2. controlled clinical trial.pt. 
3. randomized.ab. 
4. placebo.ab. 
5. drug therapy.fs. 
6. randomly.ab. 
7. trial.ab. 
8. groups.ab. 
9. or/1-8 
10. exp animals/ not humans.sh. 
11. 9 not 10 
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Appendix 4: EMBASE (OVID) Search 
Strategy   
 
1.         Malocclusion/ 
2.         ("Class III" and (Angle or Angle's or malocclusion$ or bite$)).mp. 
3.        (underbite$ or under-bite$ or "under bite$" or "reverse bite$" or reverse-bite$ or 
prognath$).mp.                                 
4.         "prominent lower front teeth".mp.                               
5.         or/1-4                           
6.         Orthodontic device/                            
7.         ("growth modif$" and (jaw or maxilla$ or mandible)).mp.                  
8.         (("fixed appliance$" or brace$) and orthodontic$).mp.                                 
9.         ((extraoral or "extra oral" or extra-oral) and traction).mp.      
10.       ("chin cap$" or chin-cap$ or chincap$).mp.                           
11.       ((facemask$ or face-mask$ or "face mask$" or "reverse headgear" or "reverse head-
gear") and orthodontic$).mp.                                  
12.       ((orthopedic$ or orthopaedic$) and (dental or orthodontic$ or 
facial)).mp.                              
13.       or/6-12                                     
14.       5 and 13 
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Appendix 5: Characteristics of Included 
Studies: 
Abdelnaby 2010
 
Methods 3 arm parallel randomised controlled trial 
Participants Number recruited: 50 growing patients (26 males and 24 females) 
Mean age: 9.7 years (range not given) 
Inclusion criteria: Patients had skeletal Class III (ANB < 1 degree) and 
mandibular prognathism (SNB > 80 degrees) and an anterior crossbite. 
Assessed for skeletal maturation with hand-wrist radiographs and shown to 
have not passed the peak of the pubertal growth spurt. 
Exclusion criteria: Not reported 
Setting: Recruited from the Faculty of Dentistry, Mansoura University, 
Mansoura, Egypt. 
Interventions Comparisons: 600g Chin cup versus 300g Chin cup versus Untreated 
control. 
Group 1: Occipital pull soft chin cup (Dentaurum, Ispringen, Germany) 
with an acrylic occlusal bite plane of a thickness that just freed the 
occlusion anteriorly. Force applied was 600g force per side. Patients were 
instructed to wear the appliance for 14 hours each day. (n=20) 
Group 2: As above using 300g per side. (n=20) 
Group 3: No orthodontic or orthopaedic treatment (n=10) 
Outcomes All measures taken prior to treatment and after 1 year. 
Outcomes relevant to the review: ANB, Wits 
Notes Sample size calculation was not described 
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Arun 1994 
Methods 3 arm parallel randomised controlled trial 
Participants Number recruited: 60 patients (26 males and 34 females). 
Mean age: 8.23 years. Range 7.44 to 8.97 years 
Inclusion criteria: ANB<2.5 degrees, Jarabak ratio greater than 59%, 
antegonial notch depth less than 2mm. 
Exclusion criteria: Not reported 
Setting: Treated in the Marmara University Dental Faculty, Turkey. 
Interventions Comparisons: Mandibular headgear versus Chin cup versus Untreated 
control. 
Group 1: Mandibular headgear group: Prefabricated tubeless bands were 
thoroughly adapted to the lower molar teeth. They were then removed 
from the mouth and orthobuccal tubes were spot welded in the middle of 
their buccal surfaces. The bands were seated back on the molar teeth and a 
facebow, with downward facing U bends of its inner bow, was inserted in 
to the tubes. The desired force was applied to the facebow. The bands were 
cemented and the patients instructed to use their appliance 24 hours later. 
The outer bow was initially positioned parallel to the inner bow. Later, its 
arms were bent downwards in the parallel position. (n=20) 
Group 2: Chin-cap group: Force directed obliquely on a line from the 
symphysis to the condyle. The head straps of the chin cap passed 1cm 
above the earlobes in the temporal region and enwrapped the cranial vault. 
Topical application of the talcum powder was recommended in case the 
metal connections of the chin cap caused allergic reactions. 
In both treatment groups, the first review was one week after the insertion 
of the appliance and thereafter at three week intervals. Both groups were 
advised to use the appliances 16 hours per day during the one year 
treatment period. Forces were maintained at 480-500g in both groups. The 
effects of any anterior crossbite were eliminated and the mandibular distal 
movement freed from occlusal interferences through application of 
posterior bite planes. (n=20) 
Group 3: No treatment. (n=20) 
Outcomes Open and closed mouth lateral cephalograms were taken of all 60 patients 
at the beginning and end of the 12 month treatment and control period. The 
condylion point was first traced on the open-mouth lateral cephalogram 
then, using its mandibular projection as a guide, it was superimposed on 
the closed-mouth lateral cephalogram on which 18 cephalometric points 
were selected for analysis. 
Outcomes relevant to this review: ANB 
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Notes Sample size calculation was not described 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Atalay 2010 
Methods 2 arm parallel randomised controlled trial 
Participants Number recruited: 30 patients (16 males and 14 females) 
Mean age: 8.04 years. 
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Inclusion criteria: Skeletal Class III (ANB < 0 degree), due to maxillary 
retrusion, or a combination of maxillary retrusion and mandibular 
protrusion. Angle Class III malocclusion with an anterior crossbite. An 
optimum SN/GoGn angle (between 26 and 38 degrees). Fully erupted 
maxillary incisors. 
Exclusion criteria: Congenitally missing teeth or congenital syndromes 
such as a cleft lip/palate. Previous orthodontic treatment. 
Setting: Patients recruited from Gazi University, Turkey 
Interventions Comparison: Tandem Traction Bow Appliance (TTBA) versus Untreated 
control. 
Group 1: The modified tandem traction bow appliance: After dental casts 
were obtained, a wax construction bite was obtained with a 5-6 mm 
vertical opening at the molar region and without any sagittal activation. 
The modified TTBA comprised an upper splint, a lower splint, and a 
traction bow. The upper splint had Adams’ clasps in the posterior region 
for retention and elastic hooks between the maxillary central and lateral 
incisors. The upper splint covered the palatal and occlusal surfaces, in 
addition to 1–2 mm of the buccal surfaces of the maxillary teeth. The 
lower splint covered the buccal and lingual surfaces of the mandibular 
teeth. Activator tubes were embedded in the posterior region of the lower 
splint. A conventional headgear facebow was modified and used as the 
traction bow. The outer bows of the face bow were cut to approximately 3 
cm and shaped as a letter ‘S’. Two elastics that exerted a force of 400–
500g on one side were worn between the labial hooks and the traction 
bow. The elastic force was directed between 35 and 40 degrees to the 
occlusal plane by arranging the position of the outer traction bows. The 
patients were instructed to wear the appliance approximately 14–16 hours 
a day. The average treatment time for this group was 9 months. (n=15) 
Group 2: Control group: Observed without treatment for 8 months. (n=15) 
Outcomes Lateral cephalometric radiographs were taken before treatment and after a 
Class I molar relationship and a minimum overjet of 2 mm was obtained. 
Pre- and post-treatment lateral cephalograms were traced by hand and 
measured by one author. Twenty-one parameters were evaluated. 
Outcomes relevant to this review: Overjet, ANB 
Notes Sample size calculation was not described. 
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Keles 2002 
Methods 2 arm parallel randomised controlled trial. 
Participants Number recruited: 20 patients (10 males and 10 females) 
Mean age: 8.54 years. Range 7.3-10.9 years. 
Inclusion criteria: Healthy patients without any hormonal or growth 
discrepancy. Anterior cross bite with Class III molar relationship. True 
class III patients. Class III patients with maxillary retrognathism. 
Exclusion criteria: Pseudo or functional Class III. 
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Setting: Recruited from Marmara University, Istanbul, Turkey. 
Interventions Comparison: Nanda facemask versus Conventional facemask. 
Group 1: Facemask with modified angle of force direction (Nanda group): 
Composed of three parts: a modified full-cover acrylic cap splint 
expansion appliance, a specially designed face bow, and a Petit type 
protraction headgear. The cap splint expansion appliance was modified by 
adding two tubes (3M Unitek, USA, item no. 325–303) on the buccal side 
of the acrylic in the premolar area. The tubes were soldered to the RME 
screw (Leone, item A620-09) and the acrylic was constructed. The purpose 
of these tubes was to accommodate the inner bows of the specially 
designed face bow. The face bow was constructed from an adjustable face 
bow (Ormco, item 200- 0227 Glendora, CA, USA). The inner bows of the 
face bow ended in the mouth with a special U-shaped bend in order to 
enter the buccal tubes from the distal, and thus be able to retain itself when 
an anterior pull was applied. In order to carry the level of force application 
above the occlusal plane, the outer bows of the face bow were bent in a 30 
degree upward direction and ended with two hook bends in order to hold 
the elastics used for the face mask. These hooks were positioned around 
the root tips of the first and second premolars and 500g of force was 
applied parallel to the Frankfort plane in an anterior direction. The same 
Petit-type face mask was used and the direction of the force was adjusted 
by moving the wire piece upward on the face mask for elastic engagement. 
(n=11) 
Group 2: Conventional facemask: This consisted of a cap splint–type rapid 
palatal expander modified by adding two hooks in the canine area. The 
purpose of these hooks was to hold the elastics in place for protraction. 
The protraction headgear was a Petit type (Ormco Corporation, Glendore, 
Calif), and a force of 500g was applied to each hook at a 30 degree angle 
to the occlusal plane. (n=9) 
In both groups, treatment was started with 10 days of rapid maxillary 
expansion. Following the expansion, a facemask was applied to the 
patients of both groups and the appliance was used for six months after the 
onset of treatment. Patients were advised to wear the face mask for a 
minimum of 16 hr/d in the first three months and 12 hours in the second 
three months. In both groups a 500g force was used. In group 1 the force 
was applied parallel to the Frankfort horizontal plane, in group 2 it was 
angled downward 30 degrees to the occlusal plane. 
Outcomes Lateral cephalometric films were taken both at the beginning and the end 
of treatment (6 months). Eighteen linear and angular cephalometric 
measurements were made for all patients. 
Outcomes relevant to this review: ANB 
Notes Sample size calculation was not described. 
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Mandall 2010 
Methods 2 arm parallel randomised controlled trial 
Participants Number recruited: 73 patients (34 males and 39 females). 
Mean age: 8.86 years. 
Inclusion criteria: 7-9 years old at the time of registration. Three or four 
incisors in crossbite in the intercuspal position. Clinical assessment of a 
class III skeletal problem. 
Exclusion criteria: Child of non-Caucasian origin. Cleft lip and palate 
and/or craniofacial syndrome. A maxillo-mandibular planes angle greater 
than 35 degrees or lower face height greater than 70 mm. Previous history 
of TMJ signs or symptoms. Lack of consent. 
Setting: Patients were recruited through UK orthodontic departments at 
five district general hospitals and three university teaching hospitals. 
Patient recruitment was optimised by writing to all general dental 
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practitioners, who referred to each unit, explaining the type of patient we 
were looking to recruit. Additionally, the consultant orthodontist in each 
centre screened up to five local primary schools for suitable children in the 
8–9 years old age group. 
Interventions Comparison: Facemask versus Untreated control 
Group 1: Facemask group: A bonded maxillary acrylic expansion device 
was placed. This consisted of a metal framework and a midline expansion 
screw to which 3 mm acrylic was adapted. The appliance was modified, if 
needed, with acrylic extending over the upper incisor edges to increase 
appliance retention. One vestibular hook was located, on each side, in the 
upper deciduous first molar position, for elastic traction. The appliance 
was cemented with glass ionomer cement, but if it later debonded, it was 
re-cemented with composite, following acid etching of the buccal and 
palatal cusps of the upper first permanent molars. For patients with 
posterior crossbites, the expansion screw was activated one quarter turn 
(0.25 mm) per day until the lingual cusps of the upper posterior teeth 
approximated the buccal cusps of the lower posterior teeth. If no transverse 
change was required, the maxillary splint was still activated once a day for 
7–10 days in order to disrupt the circum-maxillary sutures. A 
commercially available adjustable facemask was used (TP Orthodontics), 
which had bilateral vertical rods connected to both chin and forehead pads. 
This design was adjustable vertically to customize the fit. If patients 
experienced chin reddening, ventilation holes were drilled through the 
plastic chin pad or soft padding was added. Elastics were connected 
bilaterally to the adjustable midline crossbow in a downwards and 
forwards direction. Patients were asked to wear the facemask for 14 hours 
per day, continuously, during the evening and night. A co-operation 
calendar was used in an attempt to increase treatment compliance, 
although this was not formally statistically evaluated. Extra oral elastics of 
increasing strength were used (3/80 8 oz. elastics for 1–2 weeks; then 1/20 
14 oz. elastics; then 5/160 14 oz. elastics) until a force of 400g per side 
was delivered. The direction of elastic traction was downwards and 
forwards 30 degrees from the vestibular hooks on the bonded maxillary 
expander to the adjustable crossbar of the facemask. Additionally, the 
elastics could be crossed over to prevent catching or interference. (n=35) 
Group 2: Control: Following collection of initial records the patients 
allocated to the control group received no clinical intervention. They were 
recalled 15 months after registration for collection of final records. (n=38) 
Both groups were then recalled for follow up at 3 years. 
Outcomes Data were collected at the following time points:  
DC1: baseline data at trial registration. 
DC2: 15 months after baseline data collection. 
DC3: 3 years after baseline data collection. 
Cephalometric and occlusal measurements: The lateral cephalograms were 
traced by an experienced clinician who was blinded as to group allocation. 
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To determine the rotations of the maxillary and occlusal planes 
superimposition of the DC1, DC2 and DC3 lateral cephalometric 
radiographs was undertaken by another author using Bjork’s structural 
method which employs the anterior zygomatic process as the reference 
landmark. PAR scores were measured by a calibrated examiner. Overjet 
measurements were recorded from study models, with a steel millimetre 
ruler, by an experienced examiner. 
 
Psychosocial measures. The short form of the Piers–Harris children’s self-
concept scale (60 questions) was used to evaluate self-concept. This may 
have been influenced by receiving early class III treatment. 
Psychosocial/oral health related quality of life effects of treatment were 
assessed using the OASIS, which sums the impact of concern about 
appearance of teeth, including nice comments, unpleasant comments, 
teasing, avoidance of smiling, covering the mouth because of the teeth and 
self-perceived aesthetic component of the Index of Orthodontic Treatment 
Need. 
 
TMJ examination. All the orthodontists involved in the trial received 
training from a TMJ specialist before the start of the trial to ensure that the 
TMJ examination was standardized. This TMJ specialist also advised that 
an examination appropriate for this age group of children should assess 
pain (lateral and intra-auricular), clicking, crepitus, locking, muscle 
tenderness (temporalis, masseter, and lateral pterygoid), and restriction of 
jaw movement (maximum opening and lateral movement). In addition, the 
presence of forward mandibular displacement on closure was recorded. 
TMJ signs or symptoms were recorded at DC1 to ensure no patients might 
be treated with protraction facemask that may exacerbate any TMJ 
problems through potential downwards and backwards rotation at the chin 
point. No patients were excluded at baseline because of pre-existing TMJ 
signs or symptoms. 
Outcomes relevant to this review: Overjet, ANB, Piers-Harris score, 
OASIS score, TMJ outcomes. 
Notes Sample size calculation estimated that 23 children per group would give 
90% power to detect a PAR reduction of 25% with a 0.05 two sided 
significance level. 
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Vaughn 2005 
Methods 3 arm parallel randomised controlled trial 
Participants Number recruited: 46 patients (24 male and 22 female) 
Mean age: 7.33 years (range not given). 
Inclusion criteria: Zero or negative overjet on 2 or more incisors, Class 
III molar relationship with the mesiobuccal cusp of the maxillary 
permanent first molar distal to the buccal groove of the mandibular first 
permanent molar, or a mesial step terminal plane relationship of 3.0 mm or 
more if the deciduous molars were present (measured clinically). When the 
clinical or dental criteria were borderline, cephalometric criteria of ANB 
angle of 0 degrees or less, Wits analysis of 3 mm or more, and nasion 
perpendicular to A-point of 2 mm or less. 
Exclusion criteria: Any craniofacial anomaly, psychosocial impairment 
or skeletal open bite. 
Setting: University hospital in USA. 
Interventions Comparison: Facemask with expansion versus Facemask only versus 
Untreated control 
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Group 1: Facemask with expansion group: Treated with palatal expansion 
with facemask therapy. A banded, soldered, jackscrew palatal expansion 
appliance was used for each subject. Two teeth per side were banded: the 
first and second deciduous molars, the first permanent molar and the 
second deciduous molar, or the first permanent molar and premolar. The 
appliance was activated twice daily (0.5 mm/day) for a minimum of 7 
days. Soldered hooks (.045 in) were extended to the mesial of the canine 
for attachment of the force-delivering elastics. Each facemask was 
fabricated on a model made from an impression of the patient’s face. The 
facemask was fitted 7 to 10 days after the placement of the palatal 
appliance. Elastics, directed 15 to 30 degrees downward from the occlusal 
plane, delivered a force of 300 to 500g per side, as determined by a force 
gauge. The participants were instructed to wear the appliance full time at 
the beginning of treatment. Compliance was closely monitored with 
timecards. Once positive overjet and overbite and Class I 
molar occlusion were obtained, facemask wear was reduced to 14 hours a 
day. In anticipation of some relapse, over correction, approaching an end-
to-end molar relationship and overjet of 4 to 5 mm, were the treatment 
objectives. The treatment results were maintained for 3 to 6 months with 
night-time wear. (n=15) 
Group 2: Facemask only group: The protocol in group 2 was identical to 
that for group 1 except that the palatal expander was not activated. If 
patients required transverse expansion, this was performed after final 
records (T2) were obtained. (n=14) 
Group 3: Control group: Initial records (T0) were taken at enrolment and 1 
year later. (n=17) 
Outcomes Lateral cephalometric radiographs were taken at T0, T1, and T2 for the 
control group, and at T1 and T2 for the 2 treatment groups. Fifty-five 
standard cephalometric landmarks were digitised in a predetermined order 
with a digitiser accurate to 0.001 mm. Traditional cephalometric 
measurements were used to describe changes between pre-treatment, 
posttreatment, and control lateral cephalograms. Measurements included a 
combination of the Steiner, McNamara, Ricketts, Riedel, and Wits 
analyses. Changes in 55 landmarks were also evaluated relative to an x-y 
coordinate system. The Johnston analysis also was used to differentiate 
between skeletal and dental changes and to provide a method to evaluate 
the combined treatment effects (skeletal and dental) along the mean 
functional occlusal plane. 
Outcomes of relevance to the review: ANB, Wits 
Notes No sample size calculations reported, and study likely to be under powered 
to detect a difference between groups 1 and 2. 
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Xu 2001  
Methods 2 arm parallel randomised controlled trial. 
Participants Number recruited: 60 patients (27 male and 33 female) 
Mean age: 9.3 years. Range 8 to 11 years. 
Inclusion Criteria: Children with skeletal anterior cross-bite and 
abnormal facial morphology. 
Exclusion Criteria: Tooth or functional Class III patients. This lead to the 
exclusion of 20 of the 60 patients leaving 40 to be randomised. 
Setting: University hospital in China 
Interventions Comparison: Facemask versus Untreated control 
Group 1: A jackscrew rapid palatal expander welding with the bands of 
maxillary first molar and first premolar was attached to the patient 
posterior teeth. The protraction hook was located in the position of 
maxillary canines. After the first-week of expander placement, the 
expander was activated with 90 degree winding each time twice per 
day.  After two weeks, active expansion treatment was stopped and the 
maxillary protraction started. The protraction treatment used a force of 
400-500g lasted 12 hours per day. (n=20) 
Group 2: Observation only (n=20)  
Duration of Treatment: 11-13 months (mean 11.3 months) 
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Outcomes Lateral cephalometric films taken at baseline and 11-13 months (right after 
the treatment), on which 9 linear and 6 angular measurements were made. 
Outcomes relevant to this review: ANB 
Notes Sample size calculation not described. 
 
 
 
 
 
Appendix 6: Characteristics of Excluded 
Studies: 
 
Reference Reason for exclusion 
Altug
114 
Retrospective control group therefore not a prospective RCT. 
Arman
1 
Retrospective control group therefore not a prospective RCT. 
Arman
79 
Retrospective control group therefore not a prospective RCT. 
Baik
115 
Retrospective control group therefore not a prospective RCT. (author 
contacted) 
Barrett
58 
Retrospective control group therefore not a prospective RCT. 
Biren
116 
Not a randomised controlled trial. 
Cozza
53 
Not a randomised controlled trial. 
El
117 
Analysed condylar position during treatment, not an outcome of interest 
to this review. 
Gokalp
118 
Not a randomised controlled trial. 
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Goyenc
69 
Not a randomised controlled trial. 
Isci
119 
Not a randomised controlled trial. 
Jamilian
120 
Not a randomised controlled trial. 
Kurt
121 
Not a randomised controlled trial. 
Mucedero
122 
Not a randomised controlled trial. 
Pavoni
123 
Not a randomised controlled trial. 
Sar
93 
Not a randomised controlled trial. 
Tortop
80 
Retrospective control group therefore not a prospective RCT. 
Ucem
124 
Not a randomised controlled trial. 
Ulgen
47 
No randomisation process. Author contacted for clarification. 
Wilmes
125 
Patients over the age of 16. 
Yagci
126 
Not a randomised controlled trial. 
Yagci
127 
Retrospective study so therefore not a prospective randomised controlled 
trial. 
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Appendix 7: Risk of Bias Assessments 
Abdelnaby 2010 
Bias Authors’ 
judgement 
Support for judgement 
Random sequence 
generation (selection 
bias) 
Unclear The method of randomisation was not described. 
Attempts were made to contact the authors for 
clarification but we are yet to receive a response. 
Allocation concealment 
(selection bias) 
Unclear The method of allocation concealment was not 
described. Attempts were made to contact the 
authors for clarification but we are yet to receive 
a response. 
Blinding of outcome 
assessment (detection 
bias) 
Unclear There was no mention of blinding of the assessor. 
Attempts were made to contact the authors for 
clarification but we are yet to receive a response. 
Incomplete outcome 
data (attrition bias) 
Unclear There was no mention of any loss of patients 
during the study. Attempts were made to contact 
the authors for clarification but we are yet to 
receive a response. 
Selective reporting 
(reporting bias) 
Low risk The authors solely aimed to report on 
cephalometric measures and all were reported. 
Other bias High risk Stated that patients 'randomly divided into three 
groups' however groups 1 and 2 have double the 
number of patients compared to group 3. 
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Arun 1994 
Bias Authors’ 
judgement 
Support for judgement 
Random sequence 
generation (selection 
bias) 
Low risk Contact from author confirms that a random 
number generator was used for patient 
assignment on registration to the study. 
Allocation concealment 
(selection bias) 
High risk Contact from author confirms there was no 
allocation concealment used. 
Blinding of outcome 
assessment (detection 
bias) 
High risk Contact from author confirms there was no 
blinding of any assessors during the study. 
Incomplete outcome 
data (attrition bias) 
Low risk All patients completed the study and were 
included in the analysis. 
Selective reporting 
(reporting bias) 
Low risk All cephalometric measurements were recorded 
and analysed. 
Other bias Low risk Authors clarified all other queries. 
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Atalay 2010 
Bias Authors’ 
judgement 
Support for judgement 
Random sequence 
generation (selection bias) 
Low risk Contact from author confirms the use of 
random sequence generator using the 
patient application numbers. 
Allocation concealment 
(selection bias) 
High risk Contact from author confirms no 
allocation concealment was used. 
Blinding of outcome 
assessment (detection bias) 
High risk Contact from author confirms that no 
blinding of assessors was used. 
Incomplete outcome data 
(attrition bias) 
Low risk All patients completed the study and were 
accounted for in the analysis 
Selective reporting 
(reporting bias) 
Low risk All cephalometric measurements were 
recorded and analysed 
Other bias Low risk Authors clarified all other queries 
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Keles 2002 
Bias Authors’ 
judgement 
Support for judgement 
Random sequence 
generation (selection bias) 
Unclear risk The method of randomisation was not 
described. Attempts were made to contact 
the authors for clarification but we are yet 
to receive a response. 
Allocation concealment 
(selection bias) 
Unclear risk The method of allocation concealment was 
not described. Attempts were made to 
contact the authors for clarification but we 
are yet to receive a response. 
Blinding of outcome 
assessment (detection bias) 
Unclear risk There was no mention of blinding of the 
assessor. Attempts were made to contact 
the authors for clarification but we are yet 
to receive a response. 
Incomplete outcome data 
(attrition bias) 
Unclear risk There was no mention of any loss of 
patients during the study. Attempts were 
made to contact the authors for 
clarification but we are yet to receive a 
response. 
Selective reporting 
(reporting bias) 
Low risk The authors solely aimed to report on 
cephalometric measures and all were 
reported. 
Other bias Low risk None detectable 
 
 
 
 
 
 
 
 
Mandall 2010 
Bias Authors’ Support for judgement 
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judgement 
Random sequence 
generation (selection bias) 
Low risk The randomisation list was generated in 
randomisation blocks of 10 with 
stratification according to gender. 
Stratification meant that a separate 
randomisation list was generated for girls 
and boys, since gender was considered to be 
a potential confounding factor. This was 
because girls and boys will grow at different 
times during the study and, thus, potentially 
confound class III skeletal measurements. 
Allocation concealment 
(selection bias) 
Low risk The computer generated randomisation 
sequence was concealed centrally and each 
clinician telephoned a research assistant to 
receive the treatment allocation after each 
patient was registered. 
Blinding of outcome 
assessment (detection bias) 
Low risk The lateral cephalograms were traced by an 
experienced clinician who was blinded as to 
group allocation 
It was not possible to blind the clinician or 
the patient in this study. However, the trial 
was single-blind, as the researchers 
measuring the radiographs and study models 
and the statistician were blind to the 
treatment/control allocation until the data 
were analysed and the code broken. Ideally 
the clinician collecting the records at the 15 
month DC2 time point would have also been 
blinded as to group allocation. However, 
this was not attempted, because with only 
one operator was involved at each centre 
they would have had the patient’s notes in 
front of them at the time of data collection. 
Also, it was likely that the clinicians would 
have remembered who had received 
protraction facemask treatment. 
Incomplete outcome data 
(attrition bias) 
Low risk Two patients were lost to follow up in each 
group, and excluded from the analysis.  This 
is unlikely to have introduced bias. 
Selective reporting 
(reporting bias) 
Low risk Cephalometric and occlusal measurements, 
psychosocial measures and TMJ 
examination results were planned and 
reported. 
Other bias Unclear risk Some patients included in this study had a 
centric relation to centric occlusion 
displacement. This may have influenced the 
perception of the skeletal discrepancy from 
the lateral cephalogram. 
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Vaughn 2005 
Bias Authors’ 
judgement 
Support for judgement 
Random sequence 
generation (selection bias) 
Low risk We used a block randomisation table to 
assign the subjects to 1 of 3 groups after 
obtaining proper informed consent. 
Allocation concealment 
(selection bias) 
Unclear risk There was no method of allocation 
concealment. Attempts were made to 
contact the authors for clarification but we 
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are yet to receive a response. 
Blinding of outcome 
assessment (detection bias) 
Low risk The principal investigator (G.A.V.) was 
blinded to the assignment. 
Incomplete outcome data 
(attrition bias) 
Unclear risk Number of dropouts was not clear in the 
text. Attempts were made to contact the 
authors for clarification but we are yet to 
receive a response. 
Selective reporting 
(reporting bias) 
Low risk All cephalometric measures recorded and 
reported as intended. 
Other bias Low risk None detectable. 
 
 
 
 
 
 
 
 
 
 
Xu 2001 
Bias Authors’ 
judgement 
Support for judgement 
Random sequence 
generation (selection bias) 
Unclear risk The article states: 'the children were 
randomly divided into two groups' but no 
further details were given. Attempts were 
made to contact the authors for clarification 
but we are yet to receive a response. 
Allocation concealment 
(selection bias) 
Unclear risk The method of allocation concealment was 
not described. Attempts were made to 
contact the authors for clarification but we 
are yet to receive a response. 
Blinding of outcome 
assessment (detection bias) 
Unclear risk There was no mention of blinding of the 
assessor. Attempts were made to contact 
the authors for clarification but we are yet 
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to receive a response. 
Incomplete outcome data 
(attrition bias) 
Low risk All the participants with skeletal Class III 
were assessed. 
Selective reporting 
(reporting bias) 
Low risk All measures targeted were reported 
Other bias Low risk No other sources of bias identified. 
 
 
 
 
 
 
 
 
 
 
 
Appendix 8: Data Tables and Figures 
Comparison Outcome Study Effect measure P-value 
Facemask versus control Overjet (post-
treatment) 
Mandall 4.10 mm (95%CI 
3.04 to 5.16) 
<0.0001 
 Overjet (3 years’ 
follow-up) 
Mandall  2.50 mm (95%CI 
1.21 to 3.79) 
0.0001 
 Piers-Harris (post-
treatment) 
Mandall  1.50 (95%CI -0.96 
to 3.96) 
0.23 
 Piers-Harris (3 
years’ follow-up) 
Mandall  0.60 (95%CI -2.57 
to 3.77) 
0.71 
 OASIS (post-
treatment) 
Mandall  -4.00 (95%CI -7.40 
to -0.60) 
0.02 
 OASIS (3 years’ 
follow-up) 
Mandall  -3.40 (95%CI -7.99 
to 1.19) 
0.15 
Facemask with expansion 
vs Facemask only 
ANB Vaughn  -0.13 degrees 
(95%CI -1.40 to 
1.14) 
0.84 
  Wits Vaughn  -0.16 mm (95%CI -
1.63 to 1.31) 
0.83 
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Nanda facemask vs 
Conventional facemask 
ANB Keles  1.29 degrees 
(95%CI 0.16 to 
2.42) 
0.02 
600g Chin cup vs Control ANB Abdelnaby 2.00 degrees 
(95%CI 1.61 to 
2.39) 
<0.0001 
  Wits Abdelnaby 4.80 mm (95%CI 
4.13 to 5.47) 
<0.0001 
300g Chin cup vs Control ANB Abdelnaby 1.90 degrees 
(95%CI 1.43 to 
2.37) 
<0.0001 
  Wits Abdelnaby 5.10 mm (95%CI 
4.43 to 5.77) 
<0.0001 
600g Chin cup vs 300g 
Chin cup 
ANB Abdelnaby 0.10 degrees 
(95%CI -0.31 to 
0.51) 
0.63 
  Wits Abdelnaby -0.30 mm (95%CI -
1.12 to 0.52) 
0.47 
Tandem traction bow 
appliance vs Control 
Overjet Atalay 3.30 mm (95%CI 
2.46 to 4.14) 
<0.0001 
  ANB Atalay 1.70 degrees 
(95%CI 1.09 to 
2.31) 
<0.0001 
Table 3: Data for comparisons with single study 
 
 
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
Overjet [mm] 1  Mean Difference (IV, 
Fixed, 95% CI [mm]) 
Subtotals only 
   1 year follow-up 1 69 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
4.10 [3.04, 
5.16] 
   3 year follow-up 1 63 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
2.50 [1.21, 
3.79] 
ANB [Degrees] 3  Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
Subtotals only 
  1 year follow-up 3 155 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
3.93 [3.46, 
4.39] 
  3 year follow-up 1 63 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
1.40 [0.43, 
2.37] 
Piers-Harris self-
concept 
1  Mean Difference (IV, 
Fixed, 95% CI) 
Subtotals only 
  1 year follow-up 1 69 Mean Difference (IV, 1.50 [-0.96, 
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Fixed, 95% CI) 3.96] 
  3 year follow-up 1 63 Mean Difference (IV, 
Fixed, 95% CI) 
0.60 [-2.57, 
3.77] 
OASIS 1  Mean Difference (IV, 
Fixed, 95% CI) 
Subtotals only 
  1 year follow-up 1 69 Mean Difference (IV, 
Fixed, 95% CI) 
-4.00 [-7.40, -
0.60] 
  3 year follow-up 1 63 Mean Difference (IV, 
Fixed, 95% CI) 
-3.40 [-7.99, 
1.19] 
Wits [mm] 1 46 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
-3.84 [-5.31, -
2.37] 
Table 4: Facemask versus untreated control 
  
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
2.1 ANB [Degrees] 1 29 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
-0.13 [-1.40, 
1.14] 
2.2 Wits 1 29 Mean Difference (IV, 
Fixed, 95% CI) 
-0.16 [-1.63, 
1.31] 
Table 5: Facemask with expansion versus facemask only. 
 
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
3.1 ANB [Degrees] 1 20 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
1.29 [0.16, 
2.42] 
Table 6: Nanda facemask versus conventional facemask 
  
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
4.1 ANB [Degrees] 1 30 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
2.00 [1.61, 
2.39] 
4.2 Wits [mm] 1 30 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
4.80 [4.13, 
5.47] 
Table 7: 600g chin cup versus untreated control 
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Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
5.1 ANB [Degrees] 1 30 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
1.90 [1.43, 
2.37] 
5.2 Wits [mm] 1 30 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
5.10 [4.43, 
5.77] 
Table 8: 300g chin cup versus untreated control 
 
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
6.1 ANB [Degrees] 1 40 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
0.10 [-0.31, 
0.51] 
6.2 Wits [mm] 1 40 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
-0.30 [-1.12, 
0.52] 
Table 9: 600g chin cup versus 300g chin cup 
 
 
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
7.1 Overjet [mm] 1 30 Mean Difference (IV, 
Fixed, 95% CI [mm]) 
3.30 [2.46, 
4.14] 
7.2 ANB [Degrees] 1 30 Mean Difference (IV, 
Fixed, 95% CI 
[Degrees]) 
1.70 [1.09, 
2.31] 
Table 10: Tandem traction bow appliance versus untreated control 
  
Outcome or Subgroup Studies Participants Statistical Method Effect 
Estimate 
8.1 ANB 1  Other data No numeric 
data 
Table 11: Mandibular headgear versus chin cup 
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Figure 15: Forest plot for pooled data for facemask versus untreated control for ANB 
 
Appendix 9: Summary of Findings Tables 
Facemask compared to no treatment for prominent lower front teeth in children 
Patient or population: Patients with prominent lower front teeth in children 
Settings: Dental hospital 
Intervention: Facemask 
Comparison: No treatment 
Outcomes Illustrative comparative risks* 
(95% CI) 
No of 
Participants 
(studies) 
Quality of 
the evidence 
(GRADE) 
Comments 
Assumed 
risk 
Corresponding risk 
No 
treatment 
Facemask 
Overjet - 
1 year 
treatment 
Follow-up: 
at end of 
treatment 
 The mean overjet - 1 
year follow-up in the 
intervention groups was 
4.1 higher 
(3.04 to 5.16 higher) 
69 
(1 study) 
⊕⊕⊕⊝ 
moderate
1
 
 
Overjet - 
1 year 
treatment 
Follow-up: 
mean 2 
 The mean overjet - 3 
year follow-up in the 
intervention groups was 
2.5 higher 
(1.21 to 3.79 higher) 
63 
(1 study) 
⊕⊕⊕⊝ 
moderate
1
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years post 
treatment 
ANB - 1 
year 
follow-up 
Follow-up: 
mean 1 
year 
 The mean ANB - 1 year 
follow-up in the 
intervention groups was 
3.93 higher 
(3.46 to 4.39 higher) 
155 
(3 studies) 
⊕⊕⊝⊝ 
low
2,3
 
 
ANB - 3 
year 
follow-up 
 The mean ANB - 3 year 
follow-up in the 
intervention groups was 
1.4 higher 
(0.43 to 2.37 higher) 
63 
(1) 
⊕⊕⊕⊝ 
moderate
1
 
 
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in 
footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed 
risk in the comparison group and the relative effect of the intervention (and its 95% CI). 
CI: Confidence interval; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in 
the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in 
the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
Footnotes 
1
 Downgraded because only one study with this comparison reported overjet. 
2
 Downgraded because one study at low risk of bias, and 2 at unclear risk of bias 
3
 Downgraded due to Heterogeneity: Chi² = 11.29, df = 2 (P = 0.004); I² = 82% 
Table 12: Facemask compared to no treatment for prominent lower front teeth in children 
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Chin cup compared to no treatment for prominent lower front teeth in children 
Patient or population: Patients with prominent lower front teeth in children 
Settings: Dental hospital 
Intervention: Chin cup (300g or 600g) 
Comparison: No treatment 
Outcomes Illustrative comparative 
risks* (95% CI) 
No of 
Participants 
(studies) 
Quality of 
the 
evidence 
(GRADE) 
Comments 
Assumed 
risk 
Corresponding 
risk 
Control 600g Chin cup 
600g Chin 
cup 
ANB 
Follow-
up: mean 
1 years 
No 
treatment 
The mean ANB in 
the intervention 
groups was 
2 higher 
(1.61 to 2.39 
higher) 
30 
1
 
(1 study) 
⊕⊝⊝⊝ 
very low 
Insufficient evidence 
from a single study at 
high risk of bias to 
determine whether or 
not chin cup is an 
effective treatment. 
300g Chin 
cup 
ANB 
Follow-
up: mean 
1 years 
No 
treatment 
The mean ANB in 
the intervention 
groups was 
1.9 higher 
(1.43 to 2.37 
higher) 
30 
1
 
(1 study) 
⊕⊝⊝⊝ 
very low 
Insufficient evidence 
from a single study at 
high risk of bias to 
determine whether or 
not chin cup is an 
effective treatment. 
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in 
footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed 
risk in the comparison group and the relative effect of the intervention (and its 95% CI). 
CI: Confidence interval; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in 
the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in 
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the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
Footnotes 
1
 Downgraded because only one small study at high risk of bias reported this outcome. 
Table 13: Chin cup compared to no treatment for prominent lower front teeth in children 
 
Tandem traction bow appliance compared to no treatment for prominent lower front teeth 
in children 
Patient or population: Patients with prominent lower front teeth in children 
Settings: Dental hospital 
Intervention: Tandem traction bow appliance 
Comparison: Control 
Outcomes Illustrative comparative 
risks* (95% CI) 
No of 
Participants 
(studies) 
Quality of 
the 
evidence 
(GRADE) 
Comments 
Assumed 
risk 
Corresponding 
risk 
No 
Treatment 
Tandem traction 
bow appliance 
Overjet at 
end of 1 
year of 
treatment 
 The mean overjet 
in the 
intervention 
groups was 
3.3 higher 
(2.46 to 4.14 
higher) 
30 
1
 
(1 study) 
⊕⊝⊝⊝ 
very low 
Insufficient 
evidence from a 
single study at 
high risk of bias to 
determine whether 
or not tandem 
traction bow is an 
effective 
treatment. 
ANB at end 
of 1 year of 
treatment 
 The mean ANB 
in the 
intervention 
groups was 
1.7 higher 
(1.09 to 2.31 
higher) 
30 
1
 
(1 study) 
⊕⊝⊝⊝ 
very low 
Insufficient 
evidence from a 
single study at 
high risk of bias to 
determine whether 
or not tandem 
traction bow is an 
effective 
treatment. 
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in 
footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed 
risk in the comparison group and the relative effect of the intervention (and its 95% CI). 
CI: Confidence interval; 
GRADE Working Group grades of evidence 
High quality: Further research is very unlikely to change our confidence in the estimate of 
effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in 
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the estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in 
the estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
Footnotes 
1
 Downgraded because only one small study at high risk of bias reported this outcome. 
Table 14: Tandem traction bow appliance compared to no treatment for prominent lower 
front teeth in children 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
